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The presence of cofactors in enzymes broadens the range of chemical transformations catalyzed 
in Nature. Adenosylcobalamin (AdoCbl) or coenzyme-B12, is a biologically active derivative of 
vitamin B12 and an organometallic enzyme cofactor that is rare and reactive by virtue of having a 
labile organocobalt bond. To cope with the low cellular abundance and high reactivity of active 
B12 derivatives, Nature uses auxiliary proteins that support absorption, assimilation, trafficking 
and targeting of B12 precursors to B12-dependent enzymes. In humans, methylmalonyl-CoA 
mutase (MCM) is a mitochondrial protein and the only known AdoCbl-dependent enzyme. 
Genetic disruption of the gene encoding MCM, or to genes encoding the auxiliary proteins, lead 
to a rare genetic disorder known as methylmalonic acidemia. In humans, two mitochondrial 
proteins, an adenosyltransferase (ATR) and a GTPase (G-protein) chaperone of MCM, CblA, 
perform the final steps in AdoCbl synthesis and delivery to the MCM active site. ATR is a 
bifunctional enzyme with ATP-dependent cob(I)alamin adenosyltranserase and ATP-dependent 
AdoCbl transfer activities. Much of our understanding of the mammalian mitochondrial B12-
trafficking pathway is derived from clinical genetic studies on patients with cobalamin disorders 
and detailed enzymological studies of closely related bacterial orthologs particularly from 
Methylbacterium extorquens.  
The findings reported in this dissertation demonstrate the critical role of allosteric 
communication in mediating the AdoCbl trafficking from its point of synthesis on ATR to its 
delivery to MCM. Using M. extorquens ATR to mimic a C-terminal truncation mutation reported 
 xxi 
in human ATR that is associated with methylmalonic academia provided new insights into the 
biochemical basis for the pathogeneticity. The study revealed that intersubunit allosteric 
communication involving the C-terminus of ATR, which is homotrimeric, is important in 
transferring AdoCbl from ATR to MCM.  
Previous work in our group demonstrated that MeaB, the bacterial ortholog of CblA, 
functions as nucleotide-dependent molecular chaperone of MCM function that mediates AdoCbl 
transfer from ATR, protects MCM from inactivation and reactivates terminally inactivated 
MCM. In turn, MCM accelerates the intrinsically slow GTPase activity of MeaB, thus 
functioning as a GTPase activating protein (GAP). In collaboration with our crystallographer 
colleague Dr. Markos Koutmos, we have provided the first insights into a novel mechanism for 
bidirectional signaling in the MCM:MeaB complex. We demonstrate that MeaB employs an 
unusual and conformationally flexible switch III motif for enabling its chaperone and MCM’s 
GAP functions. We further demonstrate that signaling in the MCM:MeaB complex depends on 
the canonical signaling motifs, switch II and I. Switch II appears to serve an auto-inhibitory 
function to minimize the GTPase activity of uncomplexed MeaB and is important for switch III-
dependent signal transmission. Finally, we demonstrate that switch I supplies the MeaB active 
site with catalytic residues in the activated conformation found in the MCM:MeaB complex. 
Together these studies provide detailed insights into how flexible switch regions in MeaB are 








Navigating the B12 Road: Assimilation, Delivery and Disorders of Cobalamin1,2 
 
1.1 Abstract 
The reactivity of the cobalt-carbon bond in cobalamins is the key to their chemical versatility, 
supporting both methyltransfer and isomerization reactions. During evolution of higher 
eukaryotes that utilize B12, the high-reactivity of the cofactor, coupled with its low abundance, 
pressured development of an efficient system for uptake, assimilation and delivery of the 
cofactor to client B12-dependent enzymes. While most proteins suspected to be involved in B12 
trafficking were discovered by 2009, the recent identification of a new protein reveals that the 
quest for elucidating the intracellular B12 highway is still not complete. Herein, we review the 
biochemistry of cobalamin trafficking. 
1.2 Introduction 
Cofactors are variously deployed in Nature to stabilize macromolecular structures, expand 
catalytic functionality, transport gases, transduce signals and function as sensors. Due to their 
                                                
1 The content of this chapter has been published in J. Biol Chem. 2013 Mar 28; doi: 10.1074/jbc.R113.458810 
Gherasim, C., Lofgren, M. and Banerjee R. “Navigating the B12 Road: Assimilation, Delivery and Disorders of 
Cobalamin”. 
 
2 This review was produced with equal contributions from Dr. Carmen Gherasim and Michael Lofgren. Support for 
this work was provided in part by the National Institutes of Health (DK45776 and GM007767).  
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relative rarity and/or reactivity, cells have evolved strategies for sequestering and regulating the 
movement of cofactors from their point of entry into the cell to their point of docking in target 
proteins (1). A subset of cofactors, i.e., the vitamins, is obtained in a precursor form from the 
diet. Reactions catalyzing the assimilation of inactive cofactors into their active forms are 
integral to their trafficking pathways. Similarly, elaboration of metals into clusters often occurs 
on chaperones that subsequently transfer the cofactor to target proteins. The inter-protein transfer 
of metals can occur via ligand exchange reactions that are driven by differences in metal 
coordination geometry and affinity between the donor and acceptor proteins (2, 3). Seclusion of 
cofactors in chaperones during assembly/processing into their active forms minimizes unwanted 
side reactions while guided delivery averts dilution and promotes specificity of cofactor docking.  
In contrast to our understanding of cellular strategies used for trafficking metals (4-6) and 
metal clusters (7), significantly less is known about strategies for shepherding organic and 
organometallic cofactors to target proteins. This picture has however been changing with the 
convergence of clinical genetics and biochemical approaches that are beginning to illuminate an 
elaborate pathway for assimilation and delivery of dietary B12 or cobalt-containing cobalmin, a 
complex organometallic cofactor (8-10). Much less is known about how the tetrapyrrolic cousins 
of B12, e.g., iron-protoporphyrin (heme), nickel-corphin (F430) or magnesium-chlorin 
(chlorophyll) are guided to specific destinations.  
In this mini-review, we describe a model for mammalian cobalamin trafficking, which 
includes strategies for conversion of inactive precursors to the active cofactor forms, 
methylcobalamin (MeCbl) and 5´-deoxyadenosylcobalamin (AdoCbl or coenzyme B12), and 
discuss the human diseases that result from impairments along the trafficking highway. We posit 
that the navigation strategy for B12 in which a rare, reactive and high-value cofactor is 
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sequestered and targeted to client proteins, might represent a general archetype for the trafficking 
of other essential but scarce organic and organometallic cofactors.  
  
1.3 B12 Chemistry and Catalysis 
Cobalamin, discovered as the anti-pernicious anemia factor (11), was first crystallized in the 
cyanocobalamin (CNCbl) form (12), which is technically vitamin B12. The biologically active 
alkylcobalamins, MeCbl and AdoCbl, serve as cofactors for the methyltransferase and isomerase 
family of B12 enzymes respectively (13). While mammals have only two B12-dependent 
enzymes, methionine synthase and methylmalonyl-CoA mutase (MCM), there are many 
“handlers” that tailor dietary B12 and deliver it to its target enzymes (8, 9). The existence of the 
B12 trafficking pathway was suggested by careful clinical genetics studies spanning several 
decades on patients with inborn errors of cobalamin metabolism (10).  
Chemically, cobalamins comprise a central cobalt atom that is coordinated by four equatorial 
nitrogen atoms donated by the tetrapyrrolic corrin ring (Fig. 1.1a). A bulky base, 5,6-
dimethylbenzimidazole (DMB), extends from one edge of the corrin ring and coordinates the 
cobalt at the lower or α-axial position. The identity of the upper or β-axial ligand varies and 
includes cyano, aquo, methyl, and 5´-deoxyadenosyl groups. Ironically, six decades after its 
discovery, the origin and biological relevance of the cyano group remains unknown, although we 
have recently described a decyanase activity in the processing pathway (14), which allows 
utilization of CNCbl used in vitamin supplements. As the cobalt oxidation state decreases from 
3+→2+→1+, the coordination number typically decreases from 6→5→4. In solution, 
alkylcobalamins preferentially exist in the six-coordinate “base-on” state, which is in contrast to 
the “base-off/His-on” state found in the active site of both mammalian B12 enzymes (15, 16) 
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(Fig. 1.1b). Since the pKa for the “base-on” to “base-off” transition ranges from -2.13 to 3.17 
depending on the identity of the upper axial ligand (17), the “base-on” conformation 
predominates at physiological pH.  
 
Figure 1.1: Cobalamin structure and conformations. (a) Cobalamin is shown in the “base-on” 
conformation with DMB coordinating cobalt from the lower axial face of the corrin ring. The 
variable upper ligands are denoted as R on the right. (b) Alternative conformations of cobalamins 
differing with respect to the lower or α-axial ligation site. 
 
The cobalt-carbon bond in alkylcobalamins is inherently weak and holds the key to the 
reactivity of this cofactor. The bond-dissociation energies for “base-on” AdoCbl and MeCbl are 
30 kcal/mol and 37 kcal/mol, respectively (18, 19). Methyltransferases utilize MeCbl, and the 
cobalt-carbon bond is cleaved heterolytically during nucleophilic displacement of the methyl 
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group from MeCbl to an acceptor. In contrast, the isomerases cleave the cobalt-carbon bond 
homolytically to generate a radical pair: 5´-deoxyadenosyl radical and cob(II)alamin. The former 
is the “working” radical, which abstracts a hydrogen atom from the substrate to initiate a radical-
based isomerization reaction. The cobalt-carbon bond is reformed at the end of each catalytic 
cycle.  
 
1.4 Absorption, Transport and Storage of Cobalamin 
The recommended dietary allowance for cobalamin is 1-5 µg/day. A multistep process 
delivers the cofactor from the mouth into circulation and thereon to cells (Fig. 1.2) (20). 
Cobalamin released from food is first bound by haptocorrin, a salivary glycoprotein with broad 
specificity and high affinity for B12 at both neutral and acidic pH (21). In the duodenum, 
pancreatic proteases release cobalamin from the haptocorrin•B12 complex and from other 
proteins containing bound B12 that have been ingested. Subsequent binding of cobalamin to a 
second glycoprotein, intrinsic factor, facilitates its uptake by intestinal cells via cubilin/AMN 
receptor-mediated endocytosis (22). Intrinsic factor is highly selective for the physiologically 
relevant precursors of cobalamin containing an intact lower axial DMB ligand (23). Following 
internalization into enterocytes, intrinsic factor is degraded in the lysosome and cobalamin is 
released into the blood stream. An ATP-dependent transporter ABCC1 (also known as multidrug 
resistance protein 1; MRP1) present in the basolateral membrane of intestinal epithelial and other 
cells, exports cobalamin bound to transcobalamin out of the cell (24). MRP1 knock out mice 
accumulate cobalamin in the distal part of the intestine and exhibit low plasma, liver and kidney 
cobalamin (24).   
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In the bloodstream, cobalamin is associated with two carriers, transcobalamin and 
haptocorrin. It is estimated that ~20% of the circulating cobalamin is bound to transcobalamin 
while the remainder including incomplete B12 derivatives, is bound to haptocorrin (25, 26).  
 
Figure 1.2. A model for cobalamin utilization and intracellular trafficking in mammals. 
Dietary cobalamin (R-Cbl) is bound by a series of proteins found in saliva and stomach 
(haptocorrin, HC), in the duodenum (intrinsic factor, IF) and in blood (transcobalamin, TC). The 
details of these early trafficking steps are not shown in this figure. TC is recognized by the 
transcobalamin receptor (TCR) found on cell surfaces and endocytosed into the lysosome where 
R-Cbl is released following proteolytic digestion of TC. R-Cbl exits the lysosome in a process 
that requires the products of the cblJ and cblF loci. In the cytoplasm, CblC converts R-Cbl (and 
CNCbl) to cob(II)alamin (Cbl2+). Cbl2+ is partitioned to (i) the MeCbl pathway in the cytoplasm, 
which involves CblG (methionine synthase), CblE (methionine synthase reductase), and CblD 
and (ii) the AdoCbl pathway in the mitochondrion, which requires CblD, CblB 
(adenosyltransferase or ATR), and CblA (the G-protein or MeaB in bacteria) in addition to 
MCM (Mut). The question mark by the mitochondrial cobalamin transporter denotes that it is 
unidentified. Hcy, Met, M-CoA and S-CoA denote homocysteine, methionine, methylmalonyl-
CoA and succinyl-CoA respectively. 
 
Transcobalamin preferentially binds the intact cobalamin cofactor, representing a second level of 
molecular sieving out of degraded derivatives that could potentially compete with and inhibit 
B12-dependent enzymes (21, 27). Transcobalamin binds B12 avidly and mediates its transport 
across cells following complexation with the transcobalamin receptor, which is internalized into 
CblE lysosome R 
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the lysosome (28). Lysosomal degradation of transcoblamin by resident hydrolases releases 
cobalamin that is retained and further processed intracellularly.  
Despite their low sequence identity (~25%), the human cobalamin-binding proteins share a 
common evolutionary origin with transcobalamin being the oldest, followed by intrinsic factor 
and haptocorrin (29). Biochemical studies with native or recombinant proteins indicate that all 
three proteins bind a single equivalent of B12 with high affinity (Kd <1 pM), albeit with different 
specificities (21). Both transcobalamin and intrinsic factor bind cobalamin in a “base-on” 
conformation while the binding mode for haptocorrin depends on the lower axial ligand. In 
addition to cobalamins, haptocorrin can bind cobinamides, which are B12 analogs lacking the 
DMB moiety and cannot be converted to the active cofactor forms by mammals. Cobinamides 
account for ~40% of the total plasma corrins (30). While a definitive role for haptocorrin remains 
to be established, its suggested functions include a role in B12 storage and in removal of 
inhibitory corrinoid derivatives. 
 
1.5 Lysosomal Egress of Cobalamin  
Transport of cobalamin across the lysosomal membrane requires two membrane proteins 
with apparently distinct functions: CblF and CblJ (31, 32) (Fig. 1.2). Defects in the genes 
encoding these two transporters result in accumulation of B12 in the lysosome, and are classified 
as cblF (LMBD1) and the recently discovered cblJ (ABCD4) complementation groups (32, 33). 
Subcellular localization studies indicate that both LMBD1 and ABCD4 co-localize with other 
lysosomal proteins such as LAMP1; however, the precise role of each protein to the lysosomal 
export of cobalamin is unclear. Transport of free cobalamin into prokaryotes and the export of 
cobalamin from mammalian cells are fuelled by ATP hydrolysis (24, 34). ABCD4 is an ATP-
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binding cassette transporter, which might be the true lysosomal cobalamin transporter that is 
assisted by LMBD1. Alternatively, LMBD1, a putative transmembrane protein might facilitate 
passive transport of cobalamin across the lysosomal membrane. In this model, ABCD4 could be 
involved in an ATPase-driven loading of B12 from the lysosome onto LMBD1 and/or in releasing 
the cobalamin cargo from LMBD1. Functional studies using fibroblasts from patients with cblF 
and cblJ defects indicate that the two transporters can only partially complement each other and 
therefore it is likely that they act synergistically. Clearly, biochemical studies are needed to 
decipher their function in the lysosomal egress of cobalamin. We have previously suggested that 
the release of cobalamin in the acidic environment of the lysosome favors formation of the 
“base-off” conformation of the cofactor and that once cobalamin exits this compartment, it 
retains this conformation by being protein-bound (9). 
 
1.6 Early Steps in the Cytosolic Processing of Cobalamin 
Upon arrival in the cytosol, cobalamins with various upper axial ligands must be processed to 
a common intermediate that can be allocated to the MeCbl and AdoCbl synthesis pathways to 
meet cellular needs. The protein that is postulated to accept the cobalamin cargo exiting the 
lysosomal compartment is MMACHC (for methylmalonic aciduria type C and homocystinuria), 
the product of the cblC locus and hereafter referred to as CblC (9) (Fig. 1.3). Mutations in CblC 
impair both AdoCbl and MeCbl synthesis and are the most common cause of inherited 
cobalamin disorders (35).  
Human CblC is a soluble protein in which the C-terminal ~40 amino acid residues appear to 
be a recent evolutionary addition and are predicted to be highly disordered (36). Two CblC 
variants, a full length (32 kDa) and a truncated form (26 kDa), have been reported in human 
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fibroblasts and in murine tissue (36, 37).  The formation of the truncated CblC form is attributed 
to a predicted splicing variant (36). While the prevalence of the truncated CblC form is not 
known, the presence of the C-terminal domain diminishes the stability of human CblC and is not 
required for its function (36). The crystal structures of the truncated variant of human CblC do 
not reveal the presence of a C-terminally located bacterial TonB-like domain as predicted 
previously (36, 38). 
 
Figure 1.3. Biochemical functions of CblC and CblD. (a) The structure of human CblC with 
MeCbl (PDB 3SC0). MeCbl (red) is bound in a “base-off” conformation with the DMB tail 
being located in a side pocket. The flavin reductase domain is shown in yellow. The arginine 
residues that are mutated in patients are shown in stick representation. (b) Reactions catalyzed by 
CblC. (c) Localization of mutations in CblD that lead to impaired AdoCbl or MeCbl synthesis 
and the minimal length required for binding to CblC. MLS denotes mitochondrial leader 
sequence. 
 
CblC binds B12 stoichiometrically and exhibits a broad tolerance for the β-axial ligand 
accommodating C1-C6 alkyl, adenosyl, cyano and hydroxyl groups. Cobalamin is bound to CblC 
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In the structure of MeCbl-bound CblC, the cobalamin tail is secured away from the corrin ring in 
a pocket dominated by hydrophobic interactions (Fig. 1.3a) (36). CblC exhibits remarkable 
chemical versatility by its ability to cleave cobalt-carbon bonds via both homolytic and 
heterolytic mechanisms, depending on the nature of the upper axial ligand (Fig. 1.3b).  Thus, 
when an alkylcobalamin is bound to the active site, CblC catalyzes a nucleophilic displacement 
reaction in the presence of glutathione (Fig. 1.3b) (39). Mechanistically, the dealkylation reaction 
resembles the first half reaction catalyzed by methionine synthase in which the thiolate of 
homocysteine displaces the methyl group in MeCbl to form the thioether methionine and 
cob(I)alamin (Fig. 1.4a). Similarly, in the CblC-catalyzed dealkylation reaction, the glutathione 
thioether and cob(I)alamin form upon transfer of the alkyl group. When CNCbl is in the active 
site, electrons provided by free or protein-bound reduced flavin promote reductive homolytic 
cleavage leading to cyanide elimination (14, 36). Based on UV-visible and EPR spectroscopy, 
“base-off” cob(II)alamin has been identified as the other product of the reductive elimination, 
consistent with a homolytic cleavage reaction mechanism. The modest decyanation and 
dealkylation rates exhibited by CblC are apparently sufficient to handle the flux through the 
cobalamin-processing pathway to meet cellular needs. Fibroblasts derived from cblC patients 
confirm that CblC is required for processing alkyl- and cyano-cobalamins for apportioning 
dietary B12 into MeCbl and AdoCbl, respectively (40).  
Unexpectedly, the crystal structure of CblC revealed a flavin reductase fold (Fig. 1.3a) (36). 
Flavin binds at the dimer interface in two structurally related flavin reductases, BluB and 
iodotyrosine deiodinase. However, solution studies indicate that CblC exists predominantly as a 
monomer (14, 38). Unlike the structure of apo- and MeCbl-bound CblC, a dimeric crystal 
structure has been reported for AdoCbl-bound CblC, where the dimer interface is stabilized by 
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interactions between residues belonging to a highly conserved “PNRRP” loop (38). The increase 
in the proportion of dimeric CblC in the presence of AdoCbl and FMN to ~50% of the total  
 
Figure 1.4. Cofactor loading, activity and repair of the mammalian cobalamin-dependent 
enzymes. (a) Methionine synthase (MS or CblG, blue square) catalyzes the overall transfer of a 
methyl group from N5-methyl-tetrahydrofolate (CH3-THF) to homocysteine (Hcy) to give 
methionine (Met) and tetrahydrofolate (THF). Occasional oxidative escape of the cob(I)alamin 
intermediate during the catalytic cycle leads to the inactive cob(II)alamin species. The latter is 
rescued to MeCbl in a reductive methylation reaction needing NADPH, methionine synthase 
reductase (MSR or CblE) and AdoMet. This repair reaction is also likely to represent the route 
for formation of MeCbl following transfer of cob(II)alamin to apo-methionine synthase. The 



































































(b) ATR (or CblB, blue wheel) converts ATP and cob(II)alamin in the presence of a reductant to 
AdoCbl. Two equivalents of AdoCbl are bound at one time and binding of ATP to the vacant site 
triggers transfer of one AdoCbl to MCM (Mut, green circle) active site in a reaction that is gated 
by GTP hydrolysis in the G-protein chaperone (MeaB or CblA, orange rectangle). The GTP-
bound state of MeaB blocks transfer of cob(II)alamin from ATR to the MCM:G-protein 
complex. During catalysis, the cobalt-carbon bond is cleaved homolytically to initiate a radical-
based mechanism for the conversion of methylmalonyl-CoA (M-CoA) to succinyl-CoA (S-
CoA). Occasional loss of 5´-deoxyadenosine from the active site precludes reformation of 
AdoCbl at the end of the catalytic cycle and leads to inactive mutase. In this situation, the GTP-
containing chaperone promotes dissociation of cob(II)alamin, permitting reconstitution of the 
mutase with active cofactor. 
 
Studies on the ΔN11 (lacking the mitochondrial leader sequence) and the ΔN61 (starting at 
the second methionine initiation codon) CblD variants identified disordered regions in the N-
terminus of the protein that decrease its stability (37). Studies on fibroblasts derived from cblD 
patients that express shorter CblD variants reveal that the N-terminal 115 amino acids are not 
required for MeCbl synthesis (43). They are also not required for binding to CblC (44). The 
structural determinants needed for AdoCbl synthesis are harbored within a stretch of residues 
extending from 62-116 (43).  
Despite the presence of a predicted B12 binding sequence, CblD does not bind B12  suggesting 
that its involvement in intracellular B12 delivery might be exerted indirectly (37). The ability of 
CblC and CblD to form a complex that is stabilized in the presence of alkylcobalamin and 
glutathione (44), indicates that CblD might assist in the delivery of cobalamin from CblC to 
downstream targets 
 
1.7 MeCbl synthesis 
Methionine synthase, encoded by the cblG locus in humans (45-47), catalyzes the methyl 
transfer from N5-methyl-tetrahydrofate to homocysteine in two half-reactions (48) (Fig. 1.4a). 
First, the methyl group is transferred from MeCbl to homocysteine to give methionine and 
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cob(I)alamin. Second, the supernucleophilic cob(I)alamin removes the methyl group from N5-
methyl-tetrahydrofate to give tetrahydrofolate and re-forms MeCbl. Occasional oxidation of the 
bound cob(I)alamin to the inactive cob(II)alamin state necessitates repair via a reductive 
methylation reaction in which the methyl group of S-adenosylmethionine (AdoMet) is 
transferred to cobalamin in the presence of the electron donor, NADPH and the diflavin 
oxidoreductase, methionine synthase reductase, encoded by the cblE locus (Fig. 1.2).  
Mutations in cblG and cblE loci result in isolated hyperhomocysteinemia, i.e., without 
methylmalonic aciduria (49). Human methionine synthase is an ~140 kDa monomeric protein 
that is predicted to be modular like its better-studied bacterial counterpart. The four modules in 
bacterial methionine synthase bind homocysteine, N5-methyl-tetrahydrofolate, cobalamin and 
AdoMet, respectively (50). Methionine synthase reductase shuttles electrons derived from 
NADPH to methionine synthase-bound cobalamin (51, 52). The reduction of cob(II)alamin to 
cob(I)alamin by methionine synthase reductase is  thermodynamically unfavorable (53, 54) and 
driven by kinetic coupling to the exothermic methyl group transfer reaction (55). The coupled 
reactions convert cob(II)alamin to MeCbl.  Hence, in addition to rescuing inactive enzyme 
generated during the catalytic turnover cycle, it also represents a mechanism for the in situ 
synthesis of MeCbl from cob(II)alamin, loaded into the active site of apo-methionine synthase. It 
is unclear how cob(II)alamin bound to CblC is transferred to the methionine synthase and what 
role CblD plays in this process. Methionine synthase reductase has been postulated to assist in 
the cofactor docking process (56). However, while the interaction between these proteins appears 
to stimulate cofactor docking to methionine synthase in vitro, a compulsory role for methionine 
synthase reductase in vivo is unlikely as fibroblasts derived from patients with the cblE defect 
have 84-100% holo-methionine synthase (57).  
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1.8 Tailoring of AdoCbl in the Mitochondrion 
ATP-dependent cob(I)alamin adenosyl- transferase (ATR) catalyzes the synthesis of AdoCbl 
and is encoded by the cblB locus (58, 59). ATR is a bifunctional mitochondrial enzyme that 
catalyzes the formation of AdoCbl and subsequently transfers the cofactor to the lone AdoCbl-
utilizing enzyme, methylmalonyl-CoA mutase (60) (Fig. 1.4b). UV-visible, magnetic circular 
dichroism and EPR spectroscopy studies have established that cob(II)alamin is bound to ATR in 
a “base-off” 4-coordinate state (61-63). The “base-off” state makes reduction of cob(II)alamin to 
cob(I)alamin, which precedes the adenosyl transfer step,  more facile. In solution, the redox 
potential of the cob(I)alamin/cob(II)alamin  is -610 mV versus ~-500 mV for the “base-on” 
versus “base-off” states (64). It is not known if a dedicated reductase couples to the ATR. In 
vitro studies have demonstrated that flavoprotein oxidoreductases such a methionine synthase 
reductase, ferredoxin, and flavodoxin can couple to ATRs (65, 66).  
The structures of mammalian and bacterial ATRs reveal a homotrimeric organization in 
which the active sites are located between adjacent subunits (67). For the ATR from 
Methylobacterium extorquens, which is the best studied, both AdoCbl and ATP bind with 
negative cooperativity and only two of the three available active sites are used at any given time 
(60, 68). The non-equivalence of the active sites appears to be an allosteric strategy for 
controlling the delivery of AdoCbl from ATR (68). Binding of ATP triggers the ejection of a 
single equivalent of AdoCbl, presumably from the low affinity site of ATR to methylmalonyl-
CoA mutase, resulting in direct transfer of the cofactor (Fig. 1.4b). This strategy of chaperoned 
delivery averts loss of the cofactor by dilution in the cellular milieu and its conversion to the 
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unwanted “base-on” state. The pathogenic C-terminal truncation mutation compromises the 
ability of ATR to sequester AdoCbl and promotes instead, its release into solution (69).  
While the DMB “base-off” conformation of AdoCbl in ATR persists in the active site of 
MCM, the coordination environments are distinct, an important geometric consideration for the 
inter-protein cofactor transfer process. Thus, in ATR, the cobalamin is four-coordinate and the 
funnel-shaped B12 binding site leaves the DMB tail exposed to solvent. In MCM, the cobalamin 
is five-coordinate by virtue of a histidine ligand donated by the protein serving as a lower axial 
ligand. The histidine residue appears to be crucial for the translocation of AdoCbl from the active 
site of ATR to the mutase, and its substitution by alanine or asparagine impairs the transfer 
process (60). In contrast, the histidine mutations have little impact on the KD for AdoCbl binding 
from solution. These results suggest a model for cofactor transfer in which the histidine residue 
in the mutase transiently coordinates the cobalt in ATR, facilitating the relocation of AdoCbl to 
the mutase. Interestingly, mutation of conserved residues in a hinged lid motif that enforces the 
“base-off” conformation in ATR compromises mutase activity in vivo (67).  
 
1.9 A G-protein Editor of Methylmalonyl-CoA mutase 
In the reaction catalyzed by MCM, the only isomerase found in mammals, AdoCbl serves as 
a radical reservoir, generating cob(II)alamin and the reactive 5´-deoxyadenosyl radical that 
initiates the radical-based 1,2 rearrangement of the substrate (Fig. 1.4b). The cofactor-derived 
radicals recombine at the end of each catalytic cycle. Occasional escape of the 5´-
deoxyadenosine intermediate during catalytic turnover, leads to inactive enzyme, and is rescued 
by a G-protein chaperone, which uses the binding energy of GTP to power the expulsion of 
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inactive cob(II)alamin from the active site (70). MCM and the G-protein chaperone are encoded 
by the mut and cblA loci, respectively (Fig. 1.2).  
CblA or MMAA (for methylmalonic aciduria type A) is a P-loop GTPase (70, 71). Mutations 
in the cblA gene are associated with methylmalonic aciduria, reduced AdoCbl levels, and low 
mutase activity in patient fibroblasts (72, 73). A bacterial ortholog of CblA from M. extorquens, 
MeaB, is the best-studied member of this class of G-proteins and has been used as a model for 
the human CblA protein (70, 74-77).  
MeaB exhibits nanomolar affinity for MCM that is modulated by the ligands and substrates 
bound to each protein (76). The activities of MeaB and the mutase are each influenced by the 
other. MeaB has low intrinsic GTPase activity, which is enhanced ~100-fold, in the presence of 
the mutase. Hence, the mutase is a GTPase-activating protein (GAP) of MeaB. MeaB in turn, 
enhances the kcat of the mutase reaction by ~2-fold. Additionally, MeaB influences other mutase 
functions. It (i) allows the mutase to discriminate between inactive cob(II)alamin and active 
AdoCbl forms of the cofactor during ATR-dependent docking, (ii) protects the mutase against 
inactivation during turnover, and (iii) promotes the release of cob(II)alamin from inactive 
mutase.  
MeaB exhibits almost equal affinity for GTP and GDP and is expected to be predominantly 
GTP-loaded in cells due to the higher concentration of this nucleotide form. The GTPase activity 
of MeaB gates transfer of AdoCbl to the mutase active site (70). Thus, MeaB functions as a 
molecular screen that prevents assembly of MCM with incomplete cofactor precursors. The 
susceptibility of the mutase to inactivation during turnover would lead to its gradual 
accumulation in an inactive form. A two-pronged strategy is used by MeaB to avert this 
situation. First, MeaB diminishes the inactivation rate of the mutase ~3- and 15-fold in the 
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presence of GDP and GTP, respectively (75). CblA has a similar effect on the human mutase 
(70). Second, when inactive MCM is generated by the escape of 5´-deoxyadenosine from the 
active site, MeaB utilizes the binding energy of GTP to promote ejection of cob(II)alamin from 
MCM (70). CblA appears to utilize a similar mechanism as MeaB (71). The remarkable sensing 
of the 5´-deoxyadenosine moiety by MeaB, avoids inappropriate ejection of cob(II)alamin 
formed during turnover. The molecular basis of communication between MeaB and MCM awaits 
elucidation.  
Similarly, the mechanistic basis for the intricate bidirectional signaling between MeaB and 
MCM remain to be elucidated. Interestingly, a pathogenic mutation of a conserved arginine to 
cysteine at the surface of the B12 domain in the mutase nearly abolishes its GAP activity and 
destabilizes the MCM•MeaB complex (70). Strikingly, this mutation also corrupts the ability of 
MeaB to block cob(II)alamin binding to MCM, and to promote release of cob(II)alamin from the 
inactive mutase. Most G-proteins use structural motifs known as switch I and II loops that 
exhibit conformational sensitivity to nucleotide binding and hydrolysis for communicating with 
client proteins (77, 78). Missense mutations in the switch I and II loops are pathogenic and are 
located at the surface of MeaB and CblA, which might be important for interactions with the 
mutase (72, 79). Interestingly, a conserved region adjacent to the switch I and II regions in both 
MeaB and CblA also displays nucleotide-dependent conformational plasticity, and mutations in 
this region are also pathogenic (80). We speculate that this region might play a critical role in 
bidirectional communication between MCM and its G-protein partner.  
1.10 Summary 
The exciting discoveries over the past decade of genes that are culpable for cobalamin 
disorders, has opened doors to biochemical investigations of their functions. While homology 
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has served to clue us into function in some cases (e.g., ATR), the lack of relatedness at a 
sequence level to any known protein (e.g., CblC and CblD) has challenged efforts with others. 
The recent discovery of a duo of membrane proteins that lead to trapping of the cofactor in the 
lysosome when mutated, raises questions about their individual function and whether one serves 
as a bona fide transporter and the other, as an assistant. The multifunctionality of the CblC 
protein, which keeps busy as a decyanase, a dealkylase and a flavin reductase raises many 
questions about how this monomeric protein functions as a proverbial “jack-of-all trades”, and 
how it transfers the tightly bound cob(II)alamin product to client proteins. The role of CblD in 
this transfer process is a complete mystery. Similarly, the identities of the mitochondrial 
membrane importers for cobalamin are unknown as is the reductase on which the ATR function 
depends. The mechanism of busy bidirectional signaling between MCM and the G-protein 
chaperone, which orchestrates gating, guiding and repair functions, awaits elucidation. The 
combination of structural and functional studies on cobalamin trafficking proteins promises to 
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ATP-dependent cob(I)alamin adenosyltransferase (ATR) is a bifunctional protein: an enzyme 
that catalyzes the adenosylation of cob(I)alamin and an escort that delivers the product, 
adenosylcobalamin (AdoCbl or coenzyme B12), to methylmalonyl-CoA mutase (MCM), 
resulting in holoenzyme formation. Failure to assemble holo-MCM leads to methylmalonic 
aciduria. We have previously demonstrated that only 2 equiv of AdoCbl bind per homotrimer of 
ATR and that binding of ATP to the vacant active site triggers ejection of 1 equiv of AdoCbl 
from an adjacent site. In this study, we have mimicked in the Methylobacterium 
extorquens ATR, a C-terminal truncation mutation, D180X, described in a patient with 
methylmalonic aciduria, and characterized the associated biochemical penalties. We demonstrate 
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that while kcat and KMCob(I) for D180X ATR are only modestly decreased (by 3- and 2-fold, 
respectively), affinity for the product, AdoCbl, is significantly diminished (400-fold), and the 
negative cooperativity associated with its binding is lost. We also demonstrate that the D180X 
mutation corrupts ATP-dependent cofactor ejection, which leads to transfer of AdoCbl from 
wild-type ATR to MCM. These results suggest that the pathogenicity of the corresponding 
human truncation mutant results from its inability to sequester AdoCbl for direct transfer to 
MCM. Instead, cofactor release into solution is predicted to reduce the capacity for holo-MCM 
formation, leading to disease. 
 
2.2 Introduction 
Coenzyme B12 or 5′-deoxyadenoslycobalamin (AdoCbl) is a complex organometallic 
cofactor that is used in all domains of life by enzymes catalyzing diverse reactions including: 
dehydrations, intramolecular carbon skeleton rearrangements, reductive eliminations, and 
deaminations (1-3). AdoCbl comprises a central cobalt ion coordinated equatorially by four 
nitrogen atoms donated by the corrin macrocycle. A novel nucleotide base, 
dimethylbenzimidazole (DMB), occupies the lower axial coordination position while the upper 
axial position is occupied by the 5′-deoxyadenosyl group, via the organometallic cobalt–carbon 
bond. 
AdoCbl is a “high value” product that is either biosynthesized de novo by some bacteria or 
generated via adenosylation of cob(I)alamin in organisms such as mammals, which lack a de 
novo pathway for its synthesis (4). There are at least three families of ATP-dependent 
cob(I)alamin adenosyltransferases (ATR): EutT, PduO, and CobA, which catalyze the addition 
of the 5′-deoxyadenosyl group from ATP to cob(I)alamin; however, their roles in metabolism are 
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distinct. Members of the three ATR subfamilies do not share sequence or structural homology 
and represent examples of convergent evolution. In some organisms, such as Salmonella 
enterica, members of all three ATR subfamilies are used to meet metabolic requirements under 
distinct physiological conditions (4). The EutT- and PduO-type ATRs of S. enterica furnish 
AdoCbl for the B12-dependent enzymes, diol dehydratase, and ethanolamine ammonia lyase, for 
catabolism of alkane diols and growth on ethanolamine, respectively (2, 5). In contrast, CobA is 
involved in the de novo synthesis of AdoCbl (6). Humans use a PduO-type ATR for supplying 
AdoCbl to the only enzyme that uses this cofactor, i.e., MCM, for catabolism of cholesterol, 
branched chain amino acids, and odd-chain fatty acids (7, 8). 
To overcome the twin challenges posed by the lability of the cofactor in the three 
biologically relevant cobalt oxidation states and its low tissue concentration in humans, it has 
been proposed that, following intracellular delivery, B12 remains protein-bound as it is processed 
and delivered to its target enzymes (9,10). In support of this model, it has been demonstrated 
that, following AdoCbl synthesis by ATR, the cofactor is directly transferred to the active site of 
MCM via a transient protein–protein interaction (11-13). Mutations in ATR lead to deficiencies 
in the enzymatic activity of MCM, resulting in methylmalonic aciduria (7, 14, 15). 
Structure–function studies on PduO-type ATRs from Lactobacillus reuteri (16-19) and 
Methylbacterium extorquens (13, 20, 21) have provided mechanistic insights into these enzymes. 
Cob(II)alamin binds to ATR in a “base-off” conformation in which the lower axial DMB base is 
displaced from the cobalt ion (22, 23). A yet unknown mitochondrial oxidoreductase catalyzes 
the one electron reduction of mammalian ATR-bound cob(II)alamin, yielding cob(I)alamin 
(24) (eq 2.1). Cob(I)alamin is a potent nucleophile and attacks the C-5′ribosyl carbon of ATP 
forming PPPi and AdoCbl, which is “base-off” and five-coordinate (16, 25, 26). In contrast, 
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AdoCbl bound to MCM is in a six-coordinate “base-off/His-on” conformation in which a 
histidine residue donated by MCM occupies the lower axial position (1). This difference in 
coordination number results in large differences in the absorption spectra and is experimentally 
useful for locating the cofactor (13). Thus, “base-off” AdoCbl bound to ATR exhibits an 
absorbance maximum at 458 nm while “base-off/His-on” AdoCbl bound to MCM or free in 
solution has a maximum at 525 nm (13). 
Cob(II)alamin  Cob(I)alamin + ATP  AdoCbl + PPPi  (eq 2.1) 
PduO-type ATR is a homotrimer that appears to use only two of its three active sites at a time 
and exhibits negative cooperativity for substrate and product binding (13, 20, 27). In the crystal 
structure of human PduO-type ATR, 2 equivalents of ATP are bound per homotrimer (28). ATP 
binding to the vacant site in the M. extorquens ATR triggers ejection of only 1 of 2 equiv of 
AdoCbl, providing a mechanism for driving transfer to MCM in what has been described as a 
“rotary mechanism” (Figure 2.1) (27). However, the crystal structures of the L. reuteri ATR 
show occupancy of all three active sites with either ATP or cob(II)alamin (18). This difference 
may arise from altered behavior in the crystalline versus solution state or differences between 
PduO-type ATRs from different organisms. The apparent conservation of function between 
human and M. extorquens PduO-type ATR suggests that the M. extorquens ATR is a viable 





Figure 2.1. The rotary mechanism of ATP-depenent AdoCbl release/transfer. ATP binding 
triggers AdoCbl release. The ATR•product complex has two of three active sites occupied by 
AdoCbl. The three subunits of ATR are depicted in shades of blue an grey. ATP binds to the 
ATR•2AdoCbl complex and triggers the release of one equivalent of AdoCbl. 
 
The ATR monomer comprises a five-helix bundle arranged in a head-to-tail fashion relative 
to the neighboring subunit. The active sites are located at the subunit interfaces (Figure 2.2) (18, 
28). Residues at the N-terminus become ordered in response to ATP binding, and residues from 
the adjacent monomer contribute to the ATP binding site. Cobalamin binds in a C-terminal 
crevice, and backbone amides from the adjacent subunit participate in the majority of hydrogen-
bonding interactions with the amide substituents on the corrin ring (18). Two conformational 
changes accompany binding of B12: the ordering of the C-terminus and positioning of a mobile 
loop proximal to the lower axial face of B12. This loop is hydrogen bonded to B12, and its 
movement facilitates generation of four-coordinate cob(II)alamin (17). In contrast, the 
significance of the C-terminal ordering for ATR function is less well understood. Truncation of 
the final 16 residues in human ATR due to the nonsense Q234X mutation results in early onset 
methylmalonic aciduria (15). Structural studies on LrPduO-Δ183–188, an L. reuteri ATR 
missing the terminal six amino acids, revealed decreased conformational rigidity of the mobile 
loop, although cob(II)alamin was nonetheless bound in a four-coordinate “base-off” state 
(17). The LrPduO-Δ183–188 mutant exhibited a modest decrease in the catalytic efficiency 
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relative to wild-type ATR, providing limited insight into the role of the C-terminal tail and the 
biochemical basis of pathogenicity of the Q234X patient mutation (17). 
In this study, we have mimicked the Q234X mutation in the M. extorquens ATR by 
introducing the D180X mutation, which corresponds to the site of the nonsense mutation in the 
human sequence (Figure 2.3). We demonstrate that while this C-terminal truncation has modest 
effects on the steady-state kinetic parameters, the affinity for the product, AdoCbl, and allosteric 
communication between active sites leading to negative cooperativity are adversely affected. 
These changes lead to corruption of the direct transfer mechanism of AdoCbl from ATR to 
MCM and provide insights into the importance of the C-terminal loop in gating cofactor transfer 
and for communication between adjoining active sites. 
 
 
Figure 2.2. Structure of PduO-type ATR from L. reuteri with Cob(II)alamin and ATP 
bound (PDB entry 3CI1). The ATR holoenzyme is shown in ribbon representation with the 
individual subunits of the ATR trimer are colored as in Fig. 1. ATP and cobalamin are shown in 
stick representation in cyan and dark blue, respectively. The C-terminal loop (red) in one subunit 
corresponds to the boundaries of the truncation in M. extorquens D180X ATR (D180–R190). 
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2.3 Experimental Procedures 
2.3.1 Materials – MANT-ATP (2′(3′)-O-(N-methylanthraniloyl)-ATP) was purchased from Jen 
Biosciences (Germany). ATP, AdoCbl, phenylmethylsulfonyl fluoride, lysozyme, and all other 
chemical reagents were purchased from Sigma. The Stratagene Quikchange II XL Site-Directed 
Mutagenesis Kit was purchased from Agilent. 
2.3.2 Construction of the D180X ATR Mutant – The mutation was created using the 
Quikchange kit and the following primers: sense: 5′-
CAACCGCGACGGCGCCTAGGACGTGCTCTGGGTG-3′ and an antisense primary 
containing the complementary sequence. The 6xHis-wild-type ATR expression plasmid 
described previously (20) was used as template. The mutation was confirmed by nucleotide 
sequence determination at the University of Michigan DNA Sequencing Core. 
2.3.3 Expression and Purification of ATR – Escherichia coli (BL21 (DE3)) was transformed 
with plasmids encoding recombinant D180X ATR or 6xHis-wild-type ATR and grown at 37 °C 
in 1 L of Luria–Bertani media containing kanamycyin (50 µg/mL). Cultures were grown to an 
optical density at 600 nm of 0.5–0.6 and induced with either 0.1 mM (for D180X ATR) or 1 mM 
(for wild-type ATR) isopropyl-β-D-thiogalactopyranoside. Cultures were then grown at 20 °C for 
14–16 h (D180X ATR) or at 37 °C for 6–10 h (wild-type ATR) prior to harvesting. 
ATR (wild-type and D180X) was purified as follows. Bacterial pellets were suspended in 50 
mM sodium phosphate buffer, pH 8.0, containing 0.3 M KCl, 20 mM imidazole, and 1 mM 
phenylmethylsulfonyl fluoride (buffer A). Cells were lysed first by treatment with lysozyme (25 
mg/L culture; 40  000 U/mg) for 1 h with stirring at 4 °C and then disrupted by sonication as 
described previously (20). The pellet was separated by centrifugation at 19000g at 4 °C. The 
supernatant was filtered through a 0.4 µm syringe filter and diluted to 4–5 mg protein/mL before 
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loading onto a 50 mL nickel–nitrilotriacetic acid–Sepharose column pre-equilibrated with 10–20 
column volumes of buffer A. The column was washed with 10 column volumes of buffer A and 
eluted with a linear gradient of 20–300 mM imidazole in buffer A. Fractions containing the 
target protein were pooled, concentrated, dialyzed extensively against 50 mM HEPES, pH 8, 0.3 
M KCl, 5% glycerol (buffer B) at 4 °C, and then dialyzed extensively against buffer B 
containing 10 mM MgCl2 at 4 °C. This purification protocol typically yielded 15–20 mg of 
≥95% pure protein per liter of culture. 
 
Figure 2.3. Sequence comparison of select PduO-type ATRs. Multiple sequence alignment of 
PduO-type ATRs in which amino acids that are identical (black) or conserved (grey) are 
highlighted. The sequence of the human ATR includes an N-terminal 32 amino acid 
mitochondrial leader sequence. An asterisk indicates the position of residue D180. 
 
2.3.4 ATR Activity Assays – ATR activity was monitored in a steady-state assay as described 
previously and data were fit to the Michaelis–Menten equation to obtain the kinetic parameters 
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(20). The KM for ATP was determined at saturating HOCbl (55 µM) and varying ATP (from 0.5 
to 300 µM). The KM for HOCbl was determined at saturating ATP (1 mM) and varying HOCbl 
(from 0.5 to 60 µM) concentrations. 
2.3.5 Thermal Denaturation Assays – Thermal denaturation of ATR was performed to assess 
the relative stabilities of the wild-type and mutant proteins. For this, 0.5 mg/mL of purified ATR 
in buffer B containing 10 mM MgCl2was placed in a cuvette, and the temperature was increased 
from 4 to 68 °C in a Cary 100 Bio UV/vis spectrophotometer with a heating block connected to a 
Fisher Scientific Isotemp 3016S water bath. Unfolding was measured by increased light 
scattering at 600 nm in 5 °C increments until no further change in the optical density was 
observed. Data were analyzed as described previously (29). 
2.3.6 Isothermal Titration Calorimetry (ITC) – ITC experiments were performed as described 
previously (13, 30) with the exception that the temperature was maintained at 4 °C due to the 
instability of D180X ATR at ambient temperature for prolonged periods. ITC experiments, 
conducted in triplicate, were analyzed with MicroCal ORIGIN software to determine the 
bimolecular association constant (KA), binding enthalpy (ΔH°), and binding entropy (ΔS°). 
Briefly, 40–45 µM D180X ATR in 50 mM HEPES, 0.3 M KCl, 10 mM MgCl2, 5% glycerol at 
pH 8 was titrated with 45 6 µL aliquots of 1–2 mM ATP or AdoCbl. Following integration of the 
calorimetric signals in MicroCal ORIGIN software, ITC data for the titration of D180X ATR 
with ATP were fitted to a two-sites model that describes two populations of active sites that bind 
ATP with distinct thermodynamic parameters. When D180X ATR was titrated with AdoCbl, a 
single-site model was used to fit the data. The Gibbs free energy of binding either ligand was 
calculated using eqs 2 and 3. 
ΔGo = -RT ln(KA)  (eq 2.2) 
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ΔGo = ΔHo -TΔSo  (eq 2.3) 
2.3.7 Fluorescence and UV/vis Titrations – For the UV/vis titration of AdoCbl with D180X 
ATR, experiments were performed in quadruplicate, and the large hypsochromic shift from 525 
to 458 nm associated with the “base-on” to “base-off” transition for AdoCbl was used to monitor 
binding. Titrations were performed at 4 °C, and all stock solutions were kept chilled throughout 
the experiment. Briefly, 1.5–10 µM AdoCbl in 50 mM HEPES, pH 8 containing 0.3 M KCl, 10 
mM MgCl2 and 5% glycerol was titrated with 1–100 µM D180X ATR in the same buffer. 
Spectra were recorded 8–10 min after each addition of enzyme to allow binding to reach 
equilibrium. Data were fit to a hyperbolic binding isotherm to determine the dissociation 
constant, KD, for binding of AdoCbl to D180X ATR. For wild-type ATR, titrations were 
performed using 4 µM enzyme +8 µM AdoCbl and aliquots of a 1 mM ATP stock solution. The 
corresponding titration with D180X ATR was performed using 130 µM enzyme, 2 µM AdoCbl, 
and aliquots of a 20 mM ATP stock solution. Titrations of MANT-ATP with D180X were 
monitored via the quenching of MANT fluorescence upon binding. Briefly, 10–15 µM of 
MANT-ATP in 50 mM HEPES, 0.3 M KCl, 10 mM MgCl2, 5% glycerol at pH 8 was titrated 
with 100 µM D180X ATR in the same buffer to a final concentration of 35 µM protein at 4 °C. 
Fluorescence quenching was monitored at 444 nm (360 nm excitation), and its dependence on 
D180X ATR concentration was fitted to a hyperbolic binding isotherm. The MANT-ATP 
titrations were performed in triplicate. 
2.4 Results 
2.4.1 Stability of Wild-Type and D180X ATR 
During purification, the stability of the D180X mutant was noted to be lower than for wild-
type ATR, as evidenced by precipitation, especially during concentration. Comparison of the 
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thermal denaturation profiles confirmed that the D180X mutant is indeed less stable relative to 
wild-type ATR with a ΔTm = 11.1 ± 0.4 °C (Figure 2.4). 
 
Figure 2.4. Thermal melting curves for wild-type ATR (filled circles) and D180X ATR 
(hollow circles). Plots were normalized to the maximum turbidity observed at 600 nm. Protein 
unfolding was monitored as described under Experimental Procedures. 
 
2.4.2 Kinetic Characterization of Wild-Type and D180X ATR 
The initial velocity of the adenosylation reaction was monitored at 390 nm (corresponding to 
conversion of cob(I)alamin to AdoCbl) by varying the concentration of cob(I)alamin at 
saturating concentrations of ATP, or vice versa (Table 1). The apparent KMATP (8.4 ± 1.4 µM) for 
wild-type ATR is similar to previously reported values for the N-terminally His8-tagged human 
(KM, 7.2 µM) and L. reuteri (KM, 2 µM) ATRs. Similarly, the KMCob(I) for wild-type ATR is 
similar to values reported for other PduO-type ATRs (KM, 0.2–5 µM (8, 31-33)) but 5-fold lower 
than the value reported for His-tagged human ATR (31). The kcat for wild-type M. 
extorquens ATR is 4-fold larger than any value previously reported for a PduO-type ATR. 
The D180X mutation has modest effects on the steady-state kinetic parameters: KMcob(I) and 
kcat are 2- and 3.5-fold smaller, respectively, resulting in a 7-fold lower catalytic efficiency with 
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respect to the cob(I)alamin substrate (Table 2.1). The KM for ATP is unaffected by the D180X 
mutation. 
  ATP-dependence  Cob(I)alamin-dependence 
Enzyme kcat (s-1) KM (µM) kcat/KM (M-1s-1)  KM (µM) kcat/KM (M-1s-1) 
 
WT (8.9 ± 0.1) x 10-1 8.4 ± 1.4 (1.1 ± 0.3) x 105  0.4 ± 0.1 (2.5 ± 0.2) x 106 
 
D180X (2.5 ± 0.1) x 10-1 9.5 ± 1.2 (2.7 ± 0.1) x 104  0.8 ± 0.1 (3.5 ± 0.1) x 105 
aThe values represent the mean ± SD from at least three independent experiments in the 
adenosylation reaction.  
Table 2.1. Kinetic parameters of wild-type and D180X ATRa. 
 
 
2.4.3 Thermodynamic Characterization of ATP and AdoCbl Binding 
Binding of ATP to D180X ATR was characterized by ITC and by fluorescence spectroscopy 
using MANT-ATP (Figure 2.5A). A monophasic binding isotherm was obtained from the 
fluorescence titration and yielded a KD value of 5.4 ± 1.1 µM for binding of MANT-ATP to 
D180X ATR. This value is comparable to the KD value of 5.9 ± 1.4 µM reported for binding of 
the second equivalent of ATP to wild-type ATR (27). In contrast, ITC data for ATP binding to 
D180X ATR exhibits biphasic behavior (Figure 2.5B). The discrepancy between the 
fluorescence and ITC data may be derived from the low amplitude of fluorescence quenching 
upon binding of MANT-ATP to site 1 and is consistent with prior data on MANT-ATP binding 
to ATR by stopped-flow fluorescence spectroscopy (27). 
Analysis of the ITC data yielded ΔG1° and ΔG2° values of −8.1 kcal/mol and −6.9 kcal/mol 
for binding of ATP to sites 1 and 2 in D180X ATR (Table 2.2), which are virtually identical to 
those reported for wild-type ATR (−8.3 kcal/mol and −6.6 kcal/mol, respectively). However, the 
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relative contributions of the entropic and enthalpic terms to the ΔG° values differ between the 
D180X mutant and wild-type ATR. Thus, binding of ATP to sites 1 and 2 is enthalpically 
dominated (ΔH1° = −8.1 kcal/mol and ΔH2° = −6.0 kcal/mol) in wild-type ATR, while it is 
entropically driven in the D180X mutant (TΔS1° = 7.9 kcal/mol and TΔS2° = 3.4 kcal/mol). 
 
Figure 2.5. Binding of ATP to D180X ATR. (A) The inset shows a representative fluorescence 
titration of MANT-ATP (15 μM) with D180X ATR (0–40 μM) at 10 °C. (B) Representative 
calorimetric titration data for binding of ATP to ATR (50 μM) in buffer B at 4 °C. The top panel 
depicts the raw data for ATP binding in power versus time. The lower panel shows integration of 
data in the top panel, which is proportional to the heat release that accompanies binding as a 
function of time. The data in the lower panel were best fit to a two-sites binding model and 
yielded the thermodynamic parameters that govern ATP binding to D180X ATR at 4 °C (shown 
in Table 2). 
 
Binding of AdoCbl is significantly impacted in the D180X mutant, which exhibits 
a KDAdoCbl of 71 ± 24 µM (Figure 2.6A) in comparison to the 0.1 and 2.0 µM values for sites 1 
and 2 reported for the wild-type enzyme (27). The relatively low affinity of the D180X mutant 
for AdoCbl necessitated high protein concentrations during spectrophotometric titrations and was 
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limited by the instability of the mutant protein. Hence, only 83% saturation with AdoCbl could 
be observed in the spectrophotometric binding assay (Figure 2.6A). In principle, the inability to 
observe binding of 2 equiv of AdoCbl in the “base-off” state per trimer could arise from two 
possibilities: (i) only 1 equiv of AdoCbl binds to the D180X mutant in the “base-off” 
conformation while the second equivalent binds in the “base-on” conformation and (ii) the 
dissociation constant for AdoCbl binding at site 2 is 70 µM measured by spectral titration. To 
distinguish between these possibilities, AdoCbl binding was also monitored by ITC (Figure 6B).  
 
Figure 2.6. Binding of AdoCbl to D180X ATR. (A) The UV/vis spectra were obtained by 
titrating a fixed concentration of AdoCbl (7.5 µM) with increasing concentrations of D180X 
ATR (0–150 µM). Approximately 83% saturation of the two AdoCbl binding sites per trimer 
was achieved based on Δε525 = 6.69 M–1 cm–1. (B) Representative ITC data for binding of 
AdoCbl to D180X ATR (50 µM) in buffer B at 4 °C. The top panel depicts the raw data for 
AdoCbl-binding in power versus time. The lower panel shows integration of data in the top 
panel. The data in the lower panel were best fit to a single-site binding model and gave the 
thermodynamic parameters associated with binding of AdoCbl to D180X ATR at 4 °C. 
 
The calorimetric titrations showed monophasic behavior for AdoCbl binding, and the data were 
best fit to a single-binding site model with N = 2 per ATR homotrimer (Table 2.2). The ITC data 
confirm that AdoCbl binds to D180X ATR with an 700- and 35-fold weaker binding affinity at 
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sites 1 and 2 compared to wild-type enzyme. Hence, the C-terminal deletion leads to loss of 
negative cooperativity associated with AdoCbl binding to wild-type ATR. 
 
  ATPa   AdoCblb 
  Site 1 Site 2   Sites 1 and 2 
KD (µM) 0.48 ± 0.02 4.01 ± 0.61  44.1 ± 3.2 
ΔHo (kcal/mol) -0.27 ± 0.02 -3.40 ± 0.40  5.61 ± 0.26 
TΔSo (kcal/mol) 7.86 ± 0.91 3.41 ± 0.04  11.10 ± 0.63 
ΔGo (kcal/mol) -8.12 ± 0.90 -6.87 ± 0.61  -5.49 ± 0.89 
Nc (sites) 0.38 ± 0.08 1.43 ± 0.07   2.07 ± 0.07 
aITC data for ATP binding were fitted to a 2-site model. bThe isotherms for 
binding of AdoCbl to D180X ATR were best fit to a one-site model. cN 
represents the number of unique sites described by the binding model. 
 
Table 2.2. Thermodynamic parameters for binding ATP and AdoCbl to D180X ATRc. 
 
2.4.4 Corruption of the ATP-Triggered Mechanism for AdoCbl Unloading 
A characteristic of AdoCbl transfer from ATR to MCM is the ATP-stimulated ejection of 1 
equiv of AdoCbl from ATR (Figure 2.1) (20). To determine whether ATP triggers product 
release irrespective of whether one or two AdoCbl molecules are bound, wild-type ATR was 
loaded under conditions where a vast excess of active sites over AdoCbl (i.e., 100:1) resulted 
statistically, in the predominance of the 1:1 ATR:AdoCbl complex. Addition of 0–30 mM ATP 
to this complex (corresponding to a 0–200-fold excess of ATP over ATR) failed to trigger 
release of AdoCbl into solution, demonstrating that binding of ATP only releases AdoCbl from 
the low affinity site when 2 equiv of AdoCbl are bound (Figure 2.7). 
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Figure 2.7. ATP-triggered release of AdoCbl only from the low affinity site in wild-type 
ATR homotrimer. The difference in KDs for the two AdoCbl sites on ATR implies that when 
[ATR] >> [AdoCbl] (i.e., 100:1), site 2 is predominantly vacant and site 1 is occupied. The 
spectrum of “base-off” AdoCbl in the 2:1 (AdoCbl·wild-type ATR) complex where the 
concentration of AdoCbl is identical to the concentration of AdoCbl-binding sites is shown by 
the red spectrum. The green spectrum represents the release of 50% of bound Adocbl resulting 
from the addition of 30 mM ATP to the solution of 2:1 AdoCbl:ATR (red spectrum). The blue 
spectrum is of “base-off” AdoCbl when AdoCbl·ATR is 1:100 in the presence of 30 mM ATP. 
ATP is unable to stimulate release of AdoCbl under these conditions (i.e., [ATR] >> [AdoCbl]) 
when only the high affinity binding site in ATR is occupied by AdoCbl and the low affinity site 
is vacant. Titrations were performed at 4 °C and recorded after 20 min to allow binding 
equilibration. 
 
Next, the fidelity of the ATP-dependent AdoCbl release mechanism was assessed in the 
D180X mutant. The spectrum obtained upon mixing AdoCbl with a 50-fold excess of D180X 
ATR indicates that at least 85% of the cofactor is bound in the “base-off” conformation 
(Figure 2.8). The low affinity and equivalence of AdoCbl binding to sites 1 and 2 in D180X 
ATR results in a statistical distribution of populations with 0, 1, or 2 equiv of AdoCbl bound per 
ATR trimer. Addition of 5 mM ATP to this sample resulted in full displacement of all bound 
AdoCbl into solution as evidenced by the appearance of the “base-on” spectrum. The presence of 
free AdoCbl in solution was confirmed by separation using a Centricon filter. 
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Figure 2.8. Corruption of the ATP-dependent mechanism for release of a single equivalent 
of AdoCbl in the D180X mutant. Mixing AdoCbl with a 65-fold excess of D180X ATR 
generated the spectrum (filled circles) with 90% bound AdoCbl at 4 °C in buffer B. Because of 
the equivalence of sites 1 and 2 for AdoCbl binding in D180X ATR, the spectrum represents a 
statistical distribution of ATR with 0, 1, or 2 equiv of AdoCbl bound at the active site. Addition 
of 20 mM ATP resulted in the complete displacement of AdoCbl from D180X ATR (open 
circles). Thus, whereas ATP is only capable of displacing AdoCbl from the low affinity site in 
wild-type ATR when 2 equiv of AdoCbl are bound, the D180X mutant binds AdoCbl with equal 




In this study, we have mimicked the pathogenic Q243X truncation found in human ATR 
(17) to assess the role of the C-terminal tail in AdoCbl synthesis and transfer to MCM. AdoCbl 
levels are reduced 70% in cultured fibroblasts harboring the Q234X deletion, and 
supplementation with exogenous B12 provides only mild stimulation of MCM activity (15). The 
corresponding M. extorquens D180X mutant exhibits lower protein stability (Figure 2.4), and the 
steady-state kinetic parameters for adenosylation of cob(I)alamin are only modestly impacted 
(Table 2.1). The steady-state kinetic parameters of the LrPduOΔS183–188 mutant, designed to 
mimic the Q243X mutation in the human sequence, are similarly mildly affected compared to 
wild-type ATR. These results suggest that the C-terminus does not play a critical role in 
synthesis of AdoCbl, at least under in vitro conditions (17). However, as indicated by both the 
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primary sequence alignment and the crystal structure of the LrPduO ATR holoenzyme, residue 
P176 of LrPduO, and not residue S183, corresponds to Q234 in the human sequence. Hence, 
the LrPduO-ΔS183–188 sequence represents a shorter C-terminal truncation than that resulting 
from the human Q234X mutation. Importantly, while the wild-type LrPduO gene can rescue the 
growth of a ΔCobA strain of S. enterica on minimal media, LrPduO-ΔS183–188 is unable to do 
so. This is consistent with our results on the M. extorquens D180X mutant, which reveal that the 
C-terminal truncation impairs AdoCbl transfer from ATR to MCM rather than AdoCbl synthesis 
per se. 
In the structure of the L. reuteri ATR, cobalamin is bound in a hydrophobic cavity that is 
capped by an ordered C-terminal tail (18). Modeling the corresponding Q234X mutation into 
theLrPduO ATR structure suggests loss of the C-terminal cap of the B12 binding site 
(Figure 2.9). Thus, a predicted outcome of the Q234X mutation is weaker binding of AdoCbl, 
which is borne out by the significant reduction in the affinity of the D180X mutant for AdoCbl 
(Table 2). 
The C-terminal truncation is also predicted to lead to loss of key hydrogen-bonding 
interactions with AdoCbl and the mobile loop (Figure 2.10A). In the structure of LrPduO 
holoenzyme, residues R188, V186, and K184 participate in either direct or water-mediated 
hydrogen bonds, via backbone amides with the amide substituents of the corrin ring (Figure 
2.10) (18). The low C-terminal sequence conservation among the PduO-type ATRs from 
different organisms is likely due to the use of backbone amides rather than side chains for 
hydrogen bonding. Additionally, ordering of the C-terminus triggers the formation of hydrogen-
bonding contacts between B12 and residues I113 and L114 in the mobile loop. Thus, while 
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Figure 2.9. Surface representation of the cobalamin binding site in ATR. (A) Cob(II)alamin 
is shown in stick representation, while adjacent subunits colored as in Figure 2.2 are shown in 
surface representation. The C-terminal loop residues deleted in the D180X mutant are shown in 
red in (A) and are deleted in (B). The figure was created using the PDB file 3CI4. 
 
 
Figure 2.10. Map of interactions between cob(II)alamin and LrPduO ATR. (A) Shown are 
the intermolecular hydrogen-bonding interactions formed between the peptide backbone of the 
C-terminus with cobalamin and the peptide backbone of the mobile loop. All side chains have 
been excluded for clarity. The C-terminal loop missing in the D180X mutant is shown in red, and 
the backbone of residues M178, K184, V186, and R188 are shown as sticks. The mobile loop is 
shown in yellow, and the amide backbone of residues I113 and L114 are indicated. Hydrogen 
bond interactions are depicted as black dashes. (B) Shown are the proposed allosteric contacts 
between residues of the C-terminus in one subunit and helix 2 residues on the adjacent subunit. 
The C-terminus and residues L179, Y180, and R181, shown as sticks, are colored red. For 
clarity, only the amide backbone of L179 is shown. Residues E61, Q64, and D68 of the adjacent 




ordering of the C-terminus may contribute to orienting the mobile loop over the lower face of 
cobalamin, it is not required for generating “base-off” AdoCbl. 
It is unclear how the C-terminal truncation leads to loss of allosteric communication between 
adjacent active sites. The binding of ATP to the vacant site in the wild-type ATR·2AdoCbl 
product complex triggers ejection of only a single equivalent of AdoCbl, presumably from the 
low affinity site (Figure 2.7). In D180X ATR, the two binding sites are equivalent, and both 
display low affinity for AdoCbl. Binding of ATP leads to release of both equivalents of AdoCbl 
from the trimer (Figures 2.6 and 2.8). Comparison of the apo- and holo-LrPduO crystal 
structures suggests a possible mechanism for signal transmission between neighboring subunits 
(16, 18, 19). B12binding induces interactions between the C-terminus of one subunit and helix 2 
residues in the adjacent subunit (Figure 2.10B). These interactions include a salt bridge between 
R181 in the C-terminus and E61 and a hydrogen bond network between the side chains of 
residues D68 and Q64 and peptide backbone of R181 and L179 and the phenolic oxygen of 
Y180 in the neighboring C-terminus (18). A two amino acid deletion of helix 2 residues in the 
human sequence I117-Q118del results in methylmalonic aciduria. Although this deletion 
mutation has been found in a compound heterozygous state, i.e., the other ATR allele carries a 
different mutation, it would be of interest to further investigate the importance of this deletion 
mutation and other helix 2 residues in allosteric communication (14). 
In summary, our studies on the M. extorquens D180X mutation designed to mimic the patient 
Q243X mutation provide insights into the functions of ATR not only as an enzyme but also as an 
escort responsible for conveying AdoCbl to the client enzyme, MCM. The observations of 
decreased MCM activity and lower AdoCbl levels in the Q234X patient cell lines this study. We 
propose that the lower AdoCbl levels in patient fibroblasts likely reflect a combination of 
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instability of the Q234X mutant and weaker affinity for cobalamin. Supplementation of 
fibroblasts that are homozygous for the Q234X mutation with OHCbl leads to a modest increase 
in MCM activity and may result from an increased free AdoCbl pool, which facilitates 
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A Switch III Motif Relays Signaling between a B12 Enzyme and its G-protein Chaperone5,6 
 
3.1 Abstract 
Fidelity during cofactor assembly is essential for the proper functioning of metalloenzymes and 
is ensured by specific chaperones. MeaB, a G-protein chaperone for the coenzyme B12-dependent 
radical enzyme, methylmalonyl-CoA mutase (MCM), utilizes the energy of GTP binding and/or 
hydrolysis to regulate cofactor loading into MCM, protect MCM from inactivation, and rescue 
MCM inactivated during turnover. Typically, G-proteins signal to client proteins using the 
conformationally mobile switch I and II loops. Crystallographic snapshots of MeaB reported 
herein reveal a novel switch III element, which exhibits substantial conformational plasticity. 
Using alanine-scanning mutagenesis, we demonstrate that the switch III motif is critical for 
bidirectional signal transmission of the GTPase activating protein activity of MCM and the 
chaperone functions of MeaB in the MeaB:MCM complex. Mutations in the switch III loop 
                                                
5 The content of this chapter have been accepted and submitted in its final version at Nature Chemical Biology, June 
11, 2013: Lofgren, M., Padovani, D., Koutmos, M., and Banerjee, R. “Structural Determinants of Bidirectional 
Signaling Between a B12 Radical Enzyme and its Chaperone”. 
 
6 This work was supported in part by grants from the NIH (DK45776 and GM007767). The contributions were as 
follows: ML (switch III mutants characterization, data analysis, writing), DP (preparation of MeaB for 





identified in patients corrupt this inter-protein communication and lead to methylmalonic 
aciduria, an inborn error of metabolism. 
 
3.2 Introduction 
Metallochaperones control the specificity of metal insertion into active sites that harbor 
mononuclear sites, metalloclusters or organometallic cofactors (1-3). The bacterial protein MeaB 
(4) and its human ortholog CblA (5) are chaperones that regulate docking of coenzyme B12 (5´-
deoxyadenosylcobalamin or AdoCbl) into the radical enzyme methylmalonyl-CoA mutase 
(MCM) (6,7). MCM uses AdoCbl to catalyze the chemically challenging 1,2-rearrangement of 
(R)-methylmalonyl-CoA to succinyl-CoA (8). Mutations in MCM or in MMAA result in 
methylmalonic aciduria, an inborn error of metabolism (5, 9). 
MeaB belongs to the G3E family of G-proteins that include other metallochaperones needed 
for insertion of nickel into varied client proteins10. It forms a tight complex with MCM with 
affinity that is modulated by the ligand bound to each protein and that varies from 34-524 nM 
(11). MeaB binds guanosine 5´-triphosphate (GTP) and guanosine 5´-diphosphate (GDP) with 
almost equal affinity, and its low intrinsic GTPase activity is enhanced ~100-fold in the presence 
of MCM, which exhibits GTPase activating protein (GAP) activity (11). MeaB in turn, 
orchestrates a complex series of actions powered by the energy of GTP binding or hydrolysis (6). 
These functions include: (i) gating the transfer of AdoCbl from adenosyltransferase (ATR) to 
MCM while excluding the inactive precursor, cob(II)alamin, (ii) protecting MCM from oxidative 
inactivation during turnover, and (iii) reactivating via cofactor exchange, MCM that is 
inactivated during the catalytic cycle (6, 12). Chaperones with roles limited to reactivation have 
been described for methycobalamin-dependent methyltransferases and the AdoCbl-dependent 
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subfamily of eliminases (13-18). These chaperones either promote an adenosine 5´-triphosphate 
(ATP)-dependent exchange of inactive cobalamin for AdoCbl (16-19) or reduction of 
cob(II)alamin to cob(I)alamin during in situ repair of the cofactor on methyltransferases (13, 20). 
Insights into the mechanism by which complex bidirectional communication occurs between the 
active sites of MeaB and MCM have been lacking.  
Classically, small G-proteins involved in signal transduction communicate via 
conformational changes in conserved switch I and II regions in response to nucleotide binding, 
exchange and/or hydrolysis (21). MeaB is a homodimer and each subunit contains a central α/β 
G-domain core (Fig. 3.1a, light gray), a helical C-terminal extension (dark gray) contributing to 
the dimer interface and an N terminal extension (22) (medium gray). MeaB was previously 
crystallized in a nucleotide-free form (PDB ID: 2QM8; MeaB:2Pi) and in the presence of GDP 
(PDB ID: 2QM7; MeaB:2GDP)22. The location of the conformationally flexible switch I 
(residues 92-108) and II (residues 154-162) regions in MeaB used by G proteins for signal 
transmission via the canonical “spring-loaded” mechanism (23), had raised questions about how 
structural transitions accompanying nucleotide binding and GTP hydrolysis are communicated 
from MeaB to MCM (22). The presence of phosphate in the crystallization conditions used to 
obtain the nucleotide-free structure had resulted in ordering of both P loops (residues 62-70) in 
the dimer. A comparison of MeaB structures has led us to identify switch III, a third mobile loop 
whose proximity to the GTPase active site and to the conserved switch II region, suggested the 
hypothesis that this structural element is utilized for nucleotide-responsive communication 
between the MeaB and the MCM active sites. Herein, we report the structures of apo- and 5´-
guanylyl-β,γ-imidophosphate (GMPPNP)-bound MeaB and demonstrate using alanine scanning 
mutagenesis, the pleiotropic consequences of alterations to the switch III sequence. Our study 
 52 
identifies switch III as a critical structural element for bidirectional signaling between MeaB and 
MCM that is compromised by disease-causing mutations in the switch III loop identified in 
methylmalonic aciduria patients.   
3.3 Results 
3.3.1 Structure of Apo-MeaB and of MeaB•2GMPPNP 
We report two new crystal structures of apo-MeaB in the absence of phosphate or sulfate and 
in the presence of the non-hydrolyzable GTP analogue, GMPPNP (Table 3.1). The structure of 
apo-MeaB, unlike the earlier structures (22), comprises two dimers instead of a single dimer in 
the asymmetric unit (Figure 3.2). Although the overall basic dimeric unit is very similar to the 
ones reported previously (Fig. 3.1a), there are discrete differences that are localized to the active 
site and the switch regions (Figs. 3.1a, 3.2, 3.3). In one apo-MeaB dimer, the active sites are 
empty and the P-loops have conformations distinct from the reported MeaB structures. Thus, in 
the absence of nucleotides or phosphates, the P-loop rearranges and part of it forms an extra 
helical turn at the base of helix α4, increasing the number of turns from four to five (Fig. 3.2). 
This conformation is not conducive to substrate binding since the groove required for phosphate 
binding is not present. In the second dimer, there is a single GDP bound in one active site while 
the second active site is phosphate- and nucleotide-free with the P-loop in a conformation 
permissive for nucleotide binding (Fig. 3.2). We typically isolate “apo-MeaB” with 0.04 
equivalents of bound GDP, which presumably represents nucleotide that remains associated with 
the protein during purification from cell extracts. 
The MeaB•2GMPPNP structure exhibits an overall arrangement comparable to that of the 
other MeaB structures (Fig. 3.1a, Fig. 3.3). The overall conformation of the two monomers in 
each dimer is very similar. Although Mg2+ is required for the low intrinsic GTPase activity of 
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MeaB (Fig. 3.4), it is not observed in any of the structures presumably because its binding site is 
not fully formed in the absence of MCM.  
The MeaB•2GMPPNP structure exhibits an overall arrangement comparable to that of the 
other MeaB structures (Fig. 3.1a, Fig. 3.3). The overall conformation of the two monomers in 
each dimer is very similar. Although Mg2+ is required for the low intrinsic GTPase activity of 
MeaB (Fig. 3.4), it is not observed in any of the structures presumably because its binding site is 
not fully formed in the absence of MCM. The differences between the two monomers are 
primarily observed in the nucleotide-binding site and in the position of a loop (residues 177-188) 
referred to hereafter as Switch III (Fig 3.1a, right panel).  
There is clear electron density for GMPPNP in one of the monomers and residues K68, S69 
and R108 contact the β- and γ-phosphates (Fig. 3.1b, chain A). In the second monomer (chain 
B), GMPPNP is bound in a different conformation in which the γ-phosphate, which exhibits only 
partial occupancy, is re-positioned and oriented away from the active site (Fig. 3.1b). It is more 
solvent exposed and interacts only with S69 (Fig. 3.1b). In fact, the hydroxyl group of S69 in 
chain B is rotated by almost 180° and reoriented to interact directly with the oxygen atoms of the 
α- and γ-phosphate groups and with the bridging N atom. Similarly, the  ε-amino group of K68 
is rotated by ~180° with respect to its position in chain A and forms an ionic interaction with 
E154, which in turn forms a salt bridge with R108. Comparison of the structures of MeaB with 
other G-proteins such as HypB (24), suggest that residues E154 and D105 serve as Mg2+ ligands. 






Figure 3.1. Crystal structure of MeaB reveals a mobile switch III loop. (a) Comparison of 
MeaB crystal structures (gray) and the mobile Switch III regions (various colors). Apo-MeaB 
(green), MeaB•2GMPPNP (blue), MeaB•2GDP (yellow), MeaB•1GDP (mangenta), MeaB•2Pi 
(orange). (b) Close-up of the two active sites (designated as chains A and B) in the 
MeaB•2GMPPNP structure showing interactions between active site residues and the nucleotide 
(top) and composite omit electron density of the two GMPPNP ligands in the active site 
contoured at 1σ (bottom). The GMPPNP ligands as well as active site residues K68, S69, R108 
and E154 are shown in sticks. 
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Table 3.1. Data collection and refinement statistics (molecular replacement) for apo-MeaB 
and MeaB:2GMPPNP. 1Apo-MeaB (PDB ID 4JYC) has two unique dimers in the asymmetric 
unit; one has no ligands in the active site and the other dimer has one GDP bound to one of the 
two active sites. 2This structure (PDB ID 4JYB) refers to the dimer of MeaB containing two 




Figure 3.2. Structure of Apo-MeaB. (a). MeaB in its apo form crystallized as a dimer of 
dimers. One of the dimers (apo-MeaB; cyan and magenta) has no ligands (i.e. nucleotides or 
phosphates) in the active site, whereas the other has one GDP molecule in one of the active sites 
(MeaB:1GDP, yellow and green). (b) Superposition of the apo-MeaB dimer (blue) with the 
MeaB:2GDP dimer (yellow). Both faces of the dimer, related by 180° rotation are shown. The 
area of the P-loop that reorders into a helical turn in the absence of substrate is highlighted with a 
red arrow. 
 
The available MeaB structures have fairly similar dimeric arrangements and overall 
conformations as evidenced by their small comparative rmsd values (Table 3.2). The main 
differences are evident in the P-loop, switch-I and -II regions, and most significantly, in the 
switch III region. The switch III loop is found in one of three conformations or is disordered. We 
postulate that switch III exists in an ensemble of conformations and that the equilibrium between 
these conformations is influenced by the nucleotide bound in the active site in the MCM:MeaB 
!"#$
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complex. The substantial conformational flexibility of the switch III region prompted us to test 
its potential role in signaling. 
 
Figure 3.3. Comparison of MeaB crystal structures. Structures are shown in gray with the 
mobile Switch III regions shown in color as in Fig 1a but rotated by 180° so as to reveal the 
opposite face of the MeaB dimers. Apo-MeaB (green), MeaB:2GMPPNP (blue), MeaB:2GDP 
(yellow), MeaB:1GDP (magenta), MeaB:2Pi (orange). The Switch III region is disordered in all 




Figure 3.4. Mg2+ ion concentration dependence of GTP hydrolysis by MeaB. GTP hydrolysis 





Table 3.2. Comparative Rmsd values for MeaB dimers*. *MeaB:2Pi; PDB ID 2QM8. 
MeaB:2GDP; PDB ID 2QM7. MeaB:2GMPPNP; PDB ID 4JYB. Apo-MeaB (PDB ID 4JYC) 
has two unique dimers in the asymmetric unit; one has no ligands in the active site and is 
designated MeaB no ligands, and the other dimer has only one GDP bound to one of the two 
active sites and is designated MeaB:1GDP. **based on Cα atoms 
 
3.3.2 Alanine Substitution Mutagenesis of Switch III Loop 
The following switch III residues conserved in MeaB-like proteins (Fig. 3.5) were targeted 
for substitution with alanine: D182, E183, Q185, and K188. The resulting mutant proteins 
retained the ability to form high affinity complexes with apo-MCM yielding KD values ranging 
from 61 ± 9 to 117 ± 17 nM in the absence and from 30 ± 13 to 65 ±14 nM in the presence of 
GMPPNP and exhibited similar thermodynamic parameters as wild-type MeaB (Table 3.3). The 
affinity of the two MeaB active sites for nucleotide is unequal (Table 3.4). The KDs for GMPPNP 
in the mutants were comparable to that of wild-type MeaB indicating that the mutations in switch 
III do not significantly impact binding of GMPPNP, particularly at site 1. The KDs for GDP 
binding to the mutant MeaBs were also comparable to the wild-type protein within a 2- to 3-fold 
range (Table 3.4) as were the nucleotide affinities in the MeaB•apo-MCM complex, which were 
within a 5-8-fold range (Table 3.5). Interestingly, the stoichiometry of nucleotide binding to 
MeaB changes from two in the absence to one in the presence of MCM indicating half of sites 
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activity of MeaB in the complex. Collectively, these results establish that the switch III mutations 
do not significantly perturb binding of nucleotides to MeaB or formation of the complex between 
MeaB and apo-MCM.  
 
Figure 3.5. Conservation of Switch III loop residues. Conformation of a switch III loop in the 
MeaB:2GMPPNP structure (top) and sequence alignment of the switch III sequences of MeaB 
and its orthologs (bottom). Invariant residues investigated in this study are highlighted with red 




Table 3.3 Thermodynamic parameters for the binding of apo-MCM to switch III mutants 
of MeaB. These experiments were performed as described under Materials and Methods and the 
values represent the mean of at least three experiments ± S.D. 1These values are from Ref 8.  
 
 
Table 3.4 Comparison of nucleotide affinities between wild-type MeaB and switch III 
mutants. These experiments were performed as described under Methods and represent the mean 




Table 3.5. Nucleotide binding affinities in the MCM:MeaB complex. These experiments were 
performed as described under Methods and represent the mean of at least three experiments ± 
S.D. 
 
3.3.3 GAP function of MCM is Impaired in Switch III Mutants.  
The intrinsic GTPase activity of the switch III mutants is low (kobs = 0.039 to 0.043 min-1) 
and comparable to that of wild-type MeaB (Table 3.6). When MCM binds MeaB, the GTPase 
activity of Meab is increased by 100-fold. The GAP function of MCM is suppressed 10- to 25-
fold by mutants, and the Q185A and K188A mutations show the largest impairment. The 
presence of AdoCbl had no effect on the GAP activity of MCM (data not shown). Mg2+ is not 
required for nucleotide binding and in its absence MeaB binds GDP (KD = 1.4 ± 0.1 µM and 7.9 
± 2.1 µM for sites 1 and 2) and GMPPNP (0.9 ± 0.2 µM and 6.7 ± 1.7 µM for sites 1 and 2) well, 
albeit with slightly lower affinity. The Kact for Mg2+ in the GTPase assay decreases from 225 ± 
22 µM in the absence to 27 ± 8 µM in the presence of MCM (Fig. 3.4b). The 10-fold decrease in 
the Kact for Mg2+ in the presence of MCM is consistent with the organization of a higher affinity 
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binding-site in the complex versus in MeaB alone. We speculate that the occurrence of an 
incomplete active site in MeaB alone is a strategy for suppressing its intrinsic GTPase activity, 
which is activated in the MCM:MeaB complex. Collectively, these results indicate that the 
switch III loop is important for transmitting the GAP function of MCM to MeaB, which is 
expressed in part by promoting high-affinity binding of Mg2+. 
 
Table 3.6 Kinetic Parameters for GTP hydrolysis by switch III mutants of MeaB. These 
experiments were performed as described under Methods and represent the mean of at least three 
experiments ± S.D. 
 
 
3.3.4 AdoCbl Loading into MCM is Impaired in Switch III Mutants.  
ATR catalyzes the transfer of the 5´-deoxyadenosyl group of ATP to cob(I)alamin to form the 
active cofactor, AdoCbl. However, in addition to functioning as an enzyme in the cobalamin 
assimilation pathway, ATR also functions as an escort, transferring AdoCbl directly to the 
MCM:MeaB complex in a process that is gated by GTP hydrolysis by MeaB (6,25-27) and driven 
by binding of ATP to ATR (26) (Fig. 3.6a). ATP binding triggers either the transfer of one of the 
two bound equivalents of AdoCbl from ATR to the wild-type MCM:MeaB complex in the 
presence of GTP or the release of AdoCbl into solution in the presence of the non-hydrolyzable 
analog, GMPPNP (26) (Fig. 3.6b, inset).  
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Figure 3.6. The pleiotropic effects of switch III mutations. (a) Model for AdoCbl transfer 
from ATR to MCM:MeaB gated by GTP hydrolysis and triggered by ATP binding to ATR. (b) 
Representative spectra showing changes associated with the transfer of one of two equivalents of 
AdoCbl from ATR (blue) to MCM in the MCM:mutant MeaB•2GMPPNP complex (green) upon 
addition of ATP. Very little cofactor is released into solution (red). The inset shows the 
corresponding spectra in the presence of wild-type MeaB and GMPPNP in which one equivalent 
of AdoCbl is lost from ATR (blue) to solution (green) following addition of ATP. The red 
spectrum represents free AdoCbl recovered after filtration. (c) Comparison of AdoCbl 
equivalents transferred to MCM versus released into solution from ATR in the presence of 
switch III mutants of MeaB containing bound GMPPNP. (d) Spectroscopic changes 
accompanying oxidative inactivation of MCM during turnover under aerobic conditions. The 
increase in absorbance at 351 nm corresponds to oxidation of the cob(II)alamin formed during 
catalytic turnover of MCM, to H2OCbl. (e) Comparison of the inactivation time course for MCM 
in the presence of wild-type versus the D182A MeaB with GTP, GMPPNP or GDP. Inactivation 
was monitored at 351 nm. (f) Comparison of inactive cobalamin that remains bound to MCM in 
the presence of wild-type and mutant MeaBs with bound GMPPNP. The mutations in MeaB that 
are equivalent to pathogenic switch III mutations in CblA are shown in red in c and f and the 
data represent the mean ± SD of ≥3 (c) and ≥2 (f) independent experiments as described under 
Methods. 
 
Mutations in the switch III region of MeaB corrupt GTPase-gated inter-protein cofactor 
transfer (Fig. 3.6b-c). Hence, in the presence of ATP, ~1 equivalent of AdoCbl is transferred 
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from the ATR to the MCM active site in the presence of GMPPNP rather than being released into 
solution as seen with wild-type MeaB (Fig. 3.6c). These results demonstrate that mutations in 
switch III uncouple the dependence of AdoCbl transfer from ATR to MCM on GTP hydrolysis in 
MeaB. Hence, mutations in switch III corrupt the GTPase-dependent gating mechanism used by 
wild-type MeaB (6). 
3.4.5 Switch III Mutants Affect MCM Turnover and Repair.  
Multiple cycles of catalytic turnover in MCM requires (i) the deployment of a highly reactive, 
enzyme-bound radical adenosine group that facilitates substrate isoerization and (ii) geminal 
recombination between cob(II)alamin and the radical adenosine group (8). Inadvertent 
dissociation of adenosine from the MCM active site during turnover strands a reactive 
cob(II)alamin in the MCM active site. Under aerobic conditions, enzyme-boudn cob(II)alamin 
undergoes oxidation to H2OCbl and results in the terminal inactivation of MCM (12). It was 
previously shown that loss of the 5´-deoxyadenosine moiety from the active site, which precludes 
reformation of AdoCbl at the end of the catalytic cycle, is “sensed” by MeaB and triggers 
cofactor ejection in a process that utilizes the binding energy of GTP (6). Inactivation of MCM 
during enzyme-monitored turnover can be followed spectrophotometrically by formation of 
aquocobalamin (H2OCbl, 351 nm) (Fig. 3.6d-e). Under steady-state turnover conditions, H2OCbl 
forms at a rate of 9.5 x 10-3 min-1 in the MCM:MeaB complex in the absence of nucleotides. The 
presence of GTP decreases cob(II)alamin oxidation ~30-fold (kobs = 3.0 x 10-4 min-1). Although 
the switch III mutant E183A protects MCM from oxidation to a similar degree as wild-type 
MeaB (data not shown), the K188A (kobs = 0.9 x 10-4 min-1) and Q185A (kobs = 1.7 x 10-4 min-1) 
mutants offer less protection. By comparison to wild-type MeaB, the protective capacity of the 
D182A mutant is substantially less. The kobs for oxidative inactivation of MCM in the presence of 
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D182A MeaB and GTP, GMPPNP or GDP are 8.9, 8.4, and 8.2 x 10-3 min-1, respectively, and 
corresponds to an ~30-fold increase compared to wild-type MeaB (Fig. 3.6e). 
If the adenosine group is lost from the MCM active site, MeaB facilitates the ejection of 
cob(II)alamin from the MCM active site (6). To assess the role of the switch III loop in rescue of 
MCM, cob(II)alamin was mixed with an excess of apo-MCM in complex with the MeaB mutants 
followed by addition of GMPPNP. The amount of free (i.e. released) cob(II)alamin obtained in 
the filtrate following centrifugation was then estimated. In the presence of D182A, Q185A, or 
K188A variants, ~50-60% of cob(II)alamin remained bound to MCM whereas only ~30% of the 
cofactor was associated with MCM in the presence of the E183A MeaB mutant (Fig. 3.6f). In 
contrast, ~3% of cob(II)alamin was bound to MCM in the presence of wild-type MeaB. Hence 
the efficacy of cofactor expulsion is reduced 16-20-fold in three of the switch III mutants and 10-
fold in the E183 mutant.  
3.3.6 Mutations in Switch III Lead to Methylmalonic Aciduria.  
Mutations in the switch III motif of MeaB, designed to mimic disease associated switch III 
mutations in CblA, impair bidirectional signaling in the MCM:MeaB complex. Switch III 
mutations, G274S and K276E, in human CblA have been reported recently in patients with 
methylmalonic aciduria (7). The intrinsic GTPase activity and affinity for nucleotides or for 
MCM are largely unaffected in the corresponding MeaB mutants (G186S and K188E) as also 
seen with the corresponding alanine mutations in the switch III region (Tables 3.3-3.6). The 
pleiotropic biochemical penalties associated with the patient mutations mimicked in MeaB are 
virtually identical to the set of alanine mutants described above. Thus, the two patient mutations: 
(i) diminish the GAP activity of MCM (Table 3.6), (ii) uncouple AdoCbl transfer from ATR from 
the GTPase activity of MeaB in the MCM:MeaB complex (Fig. 3.6c), and (iii) inhibit release of 
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inactive cofactor from MCM (Fig. 3.6f). In the presence of GMPPNP and either K188E or 
G186S MeaB, MCM undergoes oxidative inactivation at rates of 4.1 x 10-4 min-1 and 2.5 x 10-4 
min-1, respectively. These values compare closely to the wild-type and K188A variants of MeaB, 
indicating a comparable level of protection against inactivation of MCM during catalytic 
turnover. These results establish the biological import of the switch III loop in the function of 
MeaB and by inference, MMAA. 
 
3.5 Discussion 
In this study, we have demonstrated that mutations of the conserved polar residues in the switch 
III region in MeaB impact several aspects of bidirectional signaling ranging from uncoupling 
AdoCbl transfer from GTP hydrolysis, to protection against inactivation of MCM, to rescue of 
inactivated MCM, to GAP signaling from MCM to MeaB (Figs. 3b-f and Table 1). Importantly, 
switch III mutations do not substantially impair nucleotide binding or hydrolysis by MeaB alone 
or the affinity of MeaB for MCM (Tables 3.3-3.6).  
Switch III loops, previously considered to be unique to heterotrimeric G-proteins, are 
deployed for bidirectional conveyance of signals from cell surface receptors to intracellular 
effector proteins. The switch III loops in the Gαs and GαT subunits are important for β-
adrenergic receptor-dependent adenylate cyclase activation (28) and rhodopsin-dependent cyclic 
GMP phosphodiesterase activation via transducin (29), respectively. The crystal structure of Gsα 
revealed acidic residues in switch III that interact with basic ones in switch II and suggested that 
coupled dynamical changes in these two loop regions might be important for G-protein 
activation. Indeed, mutation of a conserved glutamate residue in switch III impairs receptor-
mediated Gsα activation and the same residue is mutated in a patient with 
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pseudohypoparathyroidism (30). Mutation of the corresponding E232 residue in transducin 
decreases its downstream function, i.e., effector activation (29). Comparison of the crystal 
structures of GαT with various nucleotide ligands reveals a network of primarily ionic 
interactions between switch II and III that differ in the GDP versus GTP bound states (31). 
Exchange of GDP by GTP induces conformational changes in switch II, which are propagated to 
switch III.  
 
Figure 3.7. Switch III loop conformations. (a) Superposition of monomers of MeaB•GMPPNP, 
ArgK-like protein (PDB ID; 2P67) and MMAA (PDB ID; 2WWW). (b) Interactions between the 
switch III residue, K188 and switch II residues, V158 and E162 in the structures of MeaB•2GDP 
(yellow) and MeaB•2GMPPNP (blue). (c) Position of D182 and K188 in apo-MeaB (green), 
MeaB•2GDP (yellow), and MeaB•2Pi (orange). 
 
We posit that the switch III loop in MeaB and its orthologs are functionally equivalent to the 
corresponding element in Gα proteins. The switch III regions in the MeaB orthologs, ArgK and 
MMAA (32) are disordered in the respective crystal structures (Fig. 3.7a). Although not as well 
characterized, human CblA, like MeaB, also protects MCM against oxidative inactivation during 
turnover and reactivates it in a GTPase-dependent manner (33). While further work is needed to 
understand the relationship between nucleotide identity/occupancy and switch III conformation 
particularly in the MCM:MeaB complex, the disorder observed in the switch III region of the 
MeaB crystal structures indicates conformational plasticity of switch III in MeaB and related 
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proteins. In the MeaB•2GMPPNP monomers, K188 in the switch III loop interacts with the 
backbone carbonyl of V158 and a carboxylate oxygen of E162 in switch II (Fig. 3.7b), 
communications that are either broken or rearranged in the other MeaB structures (Fig. 3.8). 
Moreover, D182 in the conformationally mobile switch III loop in the MeaB structures is 
excursive and found in multiple and divergent orientations (Fig. 3.7c). We postulate that 
nucleotide hydrolysis triggers a conformational change in the switch I/II regions that is 
propagated via switch II to switch III, where it modulates upstream (AdoCbl docking) and 
downstream (protection and rescue of MCM) functions. The lack of sequence homology between 
the switch III loops in MeaB and the Gα proteins suggests convergent evolution of a signaling 
strategy. Collectively, the results we have reported herein suggest that switch III motifs may be 
more prevalent among the various classes of G-proteins than previously understood, and where 






Figure 3.8. Switch III loop conformations, K188 positioning and interactions in (a) 
MeaB:2GDP, (b) MeaB:GMPPNP, (c) MeaB:1GDP, (d) MeaB:2Pi, and (e) apo-MeaB 
dimers. In every panel both faces, related by 180° rotation, of the MeaB dimers are shown. The 
B average values for each chain (Ball) and SwIII regions (BSwIII) are as follows: (a) Conformation 
A: Ball=29.5  BSwIII=23.6; Conformation B: Ball=22.9  BSwIII=25.7 (b) Conformation B: Ball=42.3  
BSwIII=50.2 (c) Conformation B: Ball=40.9  BSwIII=35.2 (d) Conformation B: Ball=20.3  




3.5.1 Plasmids and construction of site-specific mutants–The plasmids containing the 
Methylobacterium extorquens AM1 MCM and ATR were described previously (6). A synthetic 
 70 
gene (GenScript Corp.) encoding M. extorquens AM1 MeaB with a 5´-Nco1 site and 3´-Xho1 
site was generated for optimal codon usage in E. coli. The synthetic MeaB gene was restriction 
digested with Nco1 and Xho1 (New England Biolabs) and sub-cloned into a pET-21d(+) 
(Novagen). Site-directed mutants were generated using a Quikchange II XL site-directed 
mutagenesis kit (Agilent) using the following mutagenic primers and the corresponding antisense 
primers:  
D182A: 5´-GCCGGGTGCAGGTGCTGAACTGCAAGGCATCAAAAAAGG-3´  





Mutations generated according to the Quickchange protocol were confirmed by nucleotide 
sequence determination at the DNA Sequencing Core Facility (University of Michigan, Ann 
Arbor). 
3.5.2 Enzyme expression and purification–Recombinant MeaB, MCM, ATR, and malonyl-
CoA synthetase were expressed and purified from One Shot® BL21 (DE3) chemically 
competent E. coli (Invitrogen) as described previously (6,34,35). Following purification, the 
enzymes were stored at -80 °C in 50 mM Hepes buffer, pH 8.0, 0.3 M KCl, 10 mM MgCl2, 5 % 
glycerol (Buffer A). 
3.5.3 Enzymatic synthesis and purification of methylmalonyl-CoA–Recombinant malonyl-
CoA synthetase was employed for synthesis of methylmalonyl-CoA as described previously 
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(34). The identity and purity of the product was determined by HPLC using a known standard 
(34).  
3.5.4 Thermodynamic characterization of complex formation and nucleotide binding– 
Isothermal titration calorimetry experiments were performed at 10 °C in Buffer A using a VPITC 
calorimeter (Microcal, Inc.) equipped with a 1.43 ml cell and a 300 µl injection syringe. Prior to 
each titration, samples were degassed using a ThermoVac degasser (Microcal, Inc.) at 5 °C for 
10 min. Each titration was performed at least in duplicate and the data were analyzed using the 
MicroCal ORIGIN program. Titrations of MeaB with nucleotides were performed with 10-25 
µM MeaB protein with 8 µl additions of 150–375 µM GDP or GMPPNP (Sigma). The binding 
affinity of MeaB to MCM was determined by titrating 4-8 µM apo-MCM ± GMPPNP (250 µM) 
with 10 µl additions of 50-100 µM MeaB ± GMPPNP (250 µM) (Sigma). The binding of 
nucleotides to the MCM:MeaB complex (with wild-type or mutant MeaBs) was performed using 
7.5–15 µM MeaB and a 2-fold molar excess of MCM to ensure saturation of the MCM:MeaB 
complex. The complexes were titrated with 8–10 µl aliquots of GDP or GMPPNP ranging in 
concentration from 100-250 µM. Single- or two-site binding models selected based on Chi-
squared distribution values for each model, were used to estimate the association constant, KA, 
entropy, TΔSo, and enthalpy, ΔHo values. The Gibbs free energy, ΔGo, was calculated using the 
following equation: ΔGo = ΔHo – TΔSo. 
3.5.5 The effect of switch III mutants on oxidative inactivation of MCM–The inactivation of 
MCM under steady-state turnover conditions in the presence of MeaB ± GMPPNP or GDP was 
followed by UV/visible spectroscopy by monitoring conversion of MCM-bound AdoCbl to 
H2OCbl at 20 °C (12). To generate the MCM:MeaB complex in 50 mM potassium phosphate, 
pH 7.5, containing 10 mM MgCl2, 3-4 mM GMPPNP was added to 35-40 µM MeaB and 
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incubated at 20 °C prior to reconstitution with 25-30 µM MCM reconstituted with an equimolar 
concentration of AdoCbl. An excess of MeaB•2GMPPNP was added to MCM to fully populate 
the MCM:MeaB complex. The reaction was initiated by addition of methylmalonyl-CoA to a 
final concentration of 7-10 mM. The rate of inactivation was monitored at 351 nm and plotted as 
a function of time. The data were fit to a single-exponential equation, A = Ao – Ape(-kt), where A is 
the absorbance at 351 nm, Ao represents the initial absorbance of cobalamin, Ap is the final 
amplitude for the conversion of AdoCbl to H2OCbl, and k is the rate constant for H2OCbl 
formation during turnover. The goodness of fit was evaluated according to the R2 value using a 
cutoff R2 value of 0.95 for each data set. The data shown are representative of at least two 
independent experiments. 
3.5.6 Cofactor transfer assays–The transfer of AdoCbl from holo-ATR to MCM in the 
MCM:MeaBGMPPNP complex was performed in the presence of stoichiometric holo-ATR and 
an excess of GMPPNP, following addition of excess ATP. The transfer or release of AdoCbl was 
monitored by UV/visible spectroscopy at 20 °C in Buffer A as described previously (6). Two 
equivalents of AdoCbl were added to ATR to generate holo-ATR. The apo-
MCM:MeaBGMPPNP complex was reconstituted by mixing MCM with two equivalents of 
MeaB and 1 mM GMPPNP in Buffer A. The two enzyme solutions were then mixed to obtain a 
final concentration of 15 µM holo-ATR (30 µM in bound AdoCbl) and 15 µM of the 
MCM:MeaBGMPPNP complex. In control samples, the reaction mixture was centrifuged at 
this stage using a Centricon YM10 concentrator (4 °C, 30 min., 16,000 x g) (Millipore). The 
presence of the “base-off” absorption spectrum of ATR-bound AdoCbl (λmax = 458 nm) verified 
that ATR did not release AdoCbl into solution upon sample dilution (i.e. when the 
MCM:MeaB•GMPPNP solution was added to it). AdoCbl transfer/release was then initiated by 
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addition of 10 mM ATP and the amount of AdoCbl released was calculated using Δε525 = 6.69 
mM-1 cm-1. The amount of AdoCbl transferred to the MCM active site was independently 
determined by centrifugation of the mixture through a Centricon YM10 concentrator (4 °C, 30 
min., 16,000 x g) (Millipore) and determining the concentration of AdoCbl in the filtrate using 
an ε525 = 8.0 mM-1 cm-1. The average ± S.D. of ≥ 3 independent experiments was used for 
reporting these results. 
3.5.7 Cob(II)alamin release assays–Loss of cob(II)alamin from MCM in the presence of MeaB 
was evaluated under anaerobic conditions in the dark, following taddition of excess GMPPNP. 
The released cob(II)alamin was quantified by absorption spectroscopy of H2OCbl (formed upon 
air oxidation) following separation of bound and free cofactor. Briefly, MCM (25-40 µM) was 
mixed with a 1.5-fold excess of D182A, E183A, Q185A, G186S, K188E, or K188A MeaB and 
incubated for 10 min with 20-35 µM cob(II)alamin at 20 °C in anaerobic Buffer A. Then, 
GMPPNP was added to a final concentration of 1-2 mM and the mixture was incubated for 10 
min at 20 °C. The sample was then removed from anaerobic conditions, incubated at 20 °C, and 
cob(II)alamin was converted to H2OCbl by air oxidation for 2 h before filtration through a 
Centricon YM10 concentrator (Millipore). H2OCbl does not dissociate from the 
MCM:MeaBGMPPNP complex (6). The UV/visible spectra of total and released cofactor were 
recorded in the unfiltered sample and the filtrate, respectively. The concentration of bound and 
free cob(II)alamin was determined using ε350 = 26.2 mM-1cm-1. The percentage of inactive 
cofactor bound was determined as the average ± S.D. of ≥ 2 independent experiments.  
3.5.8 GTPase activity of MeaB mutants–The kcat values for GTP hydrolysis by wild-type and 
mutant MeaB in the presence or absence of a 2-fold molar excess of MCM were determined 
under Vmax conditions using a discontinuous HPLC assay at a fixed and a saturating 
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concentration of GTP (10 mM) and 10 mM Mg2+ at 20 °C in Buffer A. To study the dependence 
of the GTPase activity on Mg2+, 1 mM GTP and a variable concentration of Mg2+ (0-3 mM) was 
employed in Buffer A at 20 ˚C. Briefly, reactions were quenched at 10, 20, or 30 min using 10% 
(vol/vol) 2 N trichloroacetic acid and centrifuged (4 °C, 10 min, 16,000 x g) to remove 
precipitated protein. The samples were then applied to a µ Bondapak HPLC column (Waters) 
(NH2 10 µm, 125 Å 3.9 x 300 mm) and the eluent was monitored at 254 nm. GTP and GDP 
were separated using the following HPLC program at a flow rate of 1 ml/min: 100% of Buffer 1 
(0.05 M potassium phosphate, pH 4.5) from 0-5 minutes, a linear gradient to 70 % Buffer 2 (0.80 
M potassium phosphate, pH 4.5) from 5-20 min, isocratic elution with 70% Buffer 2 from 20-25 
min, a linear gradient of 0 to 100% Buffer 1 from 25-26 min and isocratic elution with 100% 
Buffer 1 from 26-35 min. Under these conditions, GTP and GDP eluted at ~15.5 min and ~11.8 
min, respectively. Values of kcat ± S.D. represent the average at least 3 independent experiments. 
3.5.9 Crystallization and crystal harvesting–Crystals of apo-MeaB and MeaB2GMPPNP 
were obtained at 4 °C and 20 °C, respectively, by the vapor diffusion method from 4 µl 1:1 
mixtures of protein to reservoir solutions. All protein samples were concentrated to 11 mg/ml in 
50 mM Hepes buffer, pH 8.0, 2.5 mM MgCl2, 5 mM GMPPNP and 5 % glycerol for MeaB with 
GMPPNP co-crystallization and in 50 mM Hepes buffer, pH 8.0, 2.5 mM MgCl2, and 5 % 
glycerol for apo-MeaB. The reservoir solutions contained 28 % PEG400 in 50 mM HEPES, pH 
7.5, for apo-MeaB, and 28 % PEG550MME in 50 mM MES, pH 6.5 for MeaB with GMPPNP. 
Crystals of MeaB with GMPPNP were cryoprotected for a few minutes prior to flash freezing in 
liquid N2, by transfer to a solution of 22 % glycerol, 5 mM GMPPNP and 21 % PEG550MME in 
50 mM MES pH 6.75. Crystals of apo-MeaB were harvested directly from the crystallization 
drop and were subsequently flash frozen in liquid N2. Crystals of MeaB with GMPPNP were of 
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space group C2 (a= 185.6, b= 58.2, c= 76.4, β= 106.3) with 2 monomers in the asymmetric unit. 
Crystals of apo-MeaB were of space group C2 (a= 185.5, b= 58.4, c= 155.3, β= 110.1) with 4 
monomers in asymmetric unit. 
3.5.10 Data collection and structure determination–Diffraction data for apo-MeaB and 
MeaB2GMPPNP were collected at 100 K on beamline GM/CA-CAT 23-ID-D at the Advanced 
Photon Source, Argonne National Laboratory (Argonne, IL). Data for apo-MeaB and 
MeaB2GMPPNP were recorded on a Mar300 detector and processed with XDS (36) to 2.2 Å, 
and 2.1 Å resolution respectively. Phases were obtained by molecular replacement with the 
program PHASER (37) using a single monomer of the MeaB•GDP structure (22) (PDB ID 
2QM7) as a search model. Loops containing residues 62-67, 95-100, 181-186, and 225-231 were 
removed from the search model to eliminate bias. Initial simulated annealing refinement 
(torsional and cartesian) was performed for the model obtained from molecular replacement with 
phenix.refine (38) in order to remove potential model bias. Subsequently, restrained individual 
atomic refinement, and restrained isotropic individual B-factor refinement with maximum 
likelihood targets using the Babinet model for bulk solvent scaling was performed using 
REFMAC5 (39) of the CCP4 suite (40). COOT (41) was used to manually correct the incorrectly 
modeled residues. Through successive iterative rounds of refinement and manual model 
building, the remaining residues were traced in the electron density to afford the structural 
models. In later rounds of refinement, electron density near the nucleotide binding sites for one 
chain in Apo-MeaB and in both chains in MeaB•GMPPNP, were assigned and modeled with 
GDP and GMPPNP respectively. Crystallographic information as well as refinement statistics 
are provided in Supplementary Table 1. The geometric quality of the models was assessed with 
MolProbity (42). For Apo-MeaB, Molprobity reported a clash and a Molprobity score of 4.5 
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(99th percentile) and 1.73 (95th percentile) respectively, while 97.2% of the residues were in the 
favored Ramachandran plot regions with 3 outliers (0.24%). For MeaB•2GMPPNP Molprobity 
reported a clash and a molprobity score of 4.59 (99th percentile) and 1.54 (97th percentile) 
respectively, while 98.1% of the residues were in the favored Ramachandran plot regions with no 
outliers. PyMOL (43) was used to create molecular images. 
3.5.11 Summary of Statistical Analysis–Kinetic data were analyzed using either Kaleidograph 
or Microsoft Excel. MicroCal Origin was used to determine Chi-squared distribution of one- and 
two-site models ITC calorimetric titrations. 
3.5.12 Accession Codes–The crystal structure coordinates for MeaB2GMPPNP and Apo-MeaB 
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Autoinhibition and Signaling by the Switch II Motif in the G-protein Chaperone of a 
Radical B12 Enzyme7,8 
 
4.1 Abstract 
MeaB is an accessory GTPase protein involved in the assembly, protection, and reactivation of 
5´-deoxyadenosylcobalamin-dependent methyl-malonyl-CoA mutase (MCM). Mutations in the 
human ortholog of MeaB, CblA, result in methylmalonic aciduria, an inborn error of 
metabolism. G-proteins typically utilize conserved switch I and II motifs for signaling to effector 
proteins via conformational changes elicited by nucleotide-binding and hydrolysis. Our recent 
discovery that MeaB employs a novel switch III region for bidirectional signaling with MCM 
raised questions about the roles of the switch I and II motifs in MeaB. In this study, we have 
addressed the functions of conserved switch II residues by mutating these residues to alanine. 
Our results demonstrate that the GTPase activity of MeaB is auto-inhibited by switch II and that 
this loop is important for coupling nucleotide-sensitive conformational changes in switch III for 
                                                
7 The content of this chapter has been prepared for submission to J. Biol Chem.: Lofgren, M., Padovani, D., 
Koutmos, M., and Banerjee, R. “Autoinhibition and Signaling by the Switch II Motif in the G-protein Chaperone 
of a Radical B12 Enzyme”. 
 




eliciting the multiple chaperone functions of MeaB. Furthermore, we report the structure of 
MeaB crystallized in the presence of a putative transition state analog, GDPAlF4-. The absence 
of AlF4- in the resulting crystal structure and its comparison to related G-proteins supports the 
hypothesis that the catalytic site of MeaB is incomplete in the absence of the GTPase-activating 
protein, MCM, and therefore unable to stabilize the transition state analog. Favoring an inactive 
conformation in the absence of the client MCM protein represents a strategy for suppressing the 
intrinsic GTPase activity of MeaB in which the switch II loop plays an important role. 
 
4.2 Introduction 
MeaB from Methylobacterium extorquens and its human ortholog CblA, play critical roles in the 
docking of coenzyme-B12 (or 5´-deoxyadenosyl cobalamin or AdoCbl ) into the active site of the 
client enzyme, methylmalonyl-CoA mutase (MCM) (1-4). MCM belongs to the class of AdoCbl-
dependent mutases that catalyze 1,2-rearrangement reactions (5). Dietary cobalamin is 
assimilated into AdoCbl and delivered to MCM in a complex trafficking pathway (6-8). In 
humans, MCM functions in the mitochondrial catabolism of branched-chain amino acids, odd-
chain fatty acids and cholesterol, by converting methylmalonyl-CoA to succinyl-CoA. Mutations 
in the auxiliary proteins or in MCM itself, give rise to methylmalonic acidemia, an inborn error 
of metabolism that is inherited as an autosomal recessive disease (9-12). Nearly thirty pathogenic 
mutations have been described in CblA (also known as MMAA) and lead to lower AdoCbl levels 
and consequent impairment of MCM (11).  
Our understanding about the function of CblA is derived primarily from biochemical studies 
on MeaB, which belongs to the G3E family of SIMIBI (Signal recognition paticle, MinD, and 
BioD) phosphate-binding loop (P-loop) G-proteins (13). Several members of this family of 
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NTPases serve as metallochaperones. These include CooC, HypB, and UreG, accessory proteins 
involved in the maturation of nickel-containing enzymes. CooC is a Ni2+-binding ATPase that 
undergoes metal and nucleotide-dependent dimerization and catalyzes the insertion of nickel into 
carbon monooxide dehydrogenase (14).  UreG is a GTPase that is needed for the insertion of 
nickel into urease (15). HypB is activated by GTP-dependent dimerization and is needed for 
nickel insertion into the [Ni-Fe]-hydrogenase (16). Some metallochaperones bind the transition 
metal and transfer it directly to the target protein while others facilitate metal insertion but do not 
directly bind the cofactor. MeaB is an example of the latter class as it gates the transfer of 
AdoCbl from adenosyltransferase (ATR), to MCM (3) but does not itself bind the metal-
containing cofactor. GTP hydrolysis by MeaB is required for transfer of AdoCbl from ATR to 
MCM (3). Furthermore, MCM and MeaB form a complex whose affinity depends on the ligand 
bound to each protein, but is predicted to be a stable complex in vivo (4).  
Most G-proteins, including the G3E GTPases, are predicted to signal via conserved sequence 
motifs known as switch I and switch II (17-21). Together, switch I and II function as loaded 
springs that interact with the Mg2+ ion in the GTPase site and signal to target proteins by 
undergoing conformational changes in response to nucleotide binding, hydrolysis and exchange. 
In G3E G-proteins, the ExxG peptide defines the minimal consensus sequence for the switch II 
region (13). The switch I sequence is not strongly conserved with the exception of the nearly 
ubiquitously present threonine and glutamate residue in Ras-like GTPases (22). The γ-phosphate 
of GTP makes direct hydrogen bonding contacts with the main-chain amides of the conserved 
threonine and glycine residues in the switch I and II sequences, respectively. The carboxylate of 
the switch II glutamate residue forms a water-mediated contact with the Mg2+ ion that is also 
coordinated by the β- and γ-phosphate oxygen atoms. In Ras proteins, an active site water 
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molecule is activated via interaction with a conserved glutamine residue in the switch II 
consensus motif, DxxGQ, and serves as the attacking nucleophile in the GTPase reaction. In 
G3E proteins such as HypB, NifH, and SRP, the activating residue is predicted to be a conserved 
aspartate residue at position 1 in switch I (23-25). The corresponding aspartate in MeaB, D92, is 
not positioned for catalysis. It is displaced 11-14 Å from the active site in the reported structures 
(26). CblA and MeaB comprise seven central and parallel-stranded β-sheets in the G-domain and 
flanking N- and C-terminal α-helical extensions (26,27). The C-terminal extension forms a 
dimerization arm. In addition to the switch I (residues 92-108) and II (residues 154-162) loops 
two other signature G-protein motifs are present in MeaB: the P-loop and the base-specificity 
loop that extend between residues 62-70 and 200-204, respectively. The P-loop has a 
GxxGxGKST consensus sequence that interacts with the phosphate moiety of nucleotides.  
The switch II motif in MeaB-like GTPases has the following consensus sequence: 
ETVGVGQSE. In a subset of SIMIBI G-proteins, GTP-dependent conformational changes in the 
switch regions expose dimerization surfaces that are essential for their biological function (28). 
In Ras-like GTPases, GTP hydrolysis elicits a conformational change in the switch I region that 
exposes an effector domain involved in recognition of downstream target proteins (21). In the 
G3E G-proteins, the functions of switch I and II motifs in the context of their metallochaperone 
functions have not been addressed.  
In MeaB, an additional conformationally dynamic region, switch III, plays a critical role in 
bidirectional signal transduction with MCM (29). Although unrelated at a primary sequence 
level, the switch III region in the Gα-subunits of heterotrimeric G proteins is used for signal 
transmission (30-33). 
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MeaB exhibits similar affinities for GTP and GDP and, due to the relative tissue 
concentrations of each nucleotide, is expected to be predominantly GTP-loaded in the cell (2). 
The MeaB•GTP complex prevents assembly of the MCM active site by inactive precursors of 
AdoCbl (3). Comparison of the apo- and GDP-bound structures of MeaB with other G3E family 
members suggests that switch I and II are not in their catalytically active conformations (Fig. 
4.1). The association of MeaB with MCM results in an ~100-fold rate enhancement of the 
GTPase reaction and also increases the affinity for GTP (2). Thus, MCM functions as a GTPase-
activating protein (GAP) for MeaB. Two models for GAP activation of MeaB by MCM include: 
(i) contribution in trans of one or more catalytic residues by MCM to the active site of MeaB and 
(ii) induction of a conformational change in the MeaB•MCM complex that brings the active site 
residues of MeaB into catalytic register (34,35).  
 
Figure 4.1. Schematic representation of the interactions between GTP and MeaB or HypB. 
The active sites of a) MeaB•GMPPNP (PDB 4JYC) and b) HypBGTPγS (PDB 2HF8) are 
shown. The residues in MeaB that, based on sequence and structural homology to other G3E 
proteins, are predicted to be equivalent to those in the HypB active site are shown on the left and 
are boxed. Residues on the rate of the back slash identify active site residues in HypB. 
 
In addition to gating the transfer of AdoCbl from ATR to MCM, MeaB also functions to 
protect MCM from inactivation during catalytic turnover and to rescue MCM that is inactivated 
(2,3). Thus, in the presence of either GDP or GTP, MeaB slows the rate of MCM inactivation 
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during catalysis by 30-fold and the exchange of GDP for GTP drives the ejection of inactive 
cofactor from the active site of MCM. While limited, biochemical studies support a role for 
CblA that is analogous to the better-characterized MeaB in forming a complex with MCM, 
protecting MCM from inactivation, and rescuing inactive MCM (36). Furthermore, human MCM 
also exhibits GAP activity with respect to CblA (27).  
In this study, we have interrogated the role of the switch II motif in mediating the chaperone 
functions of MeaB and in transmitting the GAP function of MCM. To this end, we have 
employed alanine-substitution mutagenesis at conserved positions in switch II to learn about 
their role in MeaB function. We demonstrate that switch II mutations compromise regulation of 
AdoCbl transfer from ATR to the MCM•MeaB complex, reduce protection of MCM from 
inactivation during turnover, and impair ejection of inactive cofactor from the active site of 
MCM. Remarkably, a subset of switch II mutations activates the intrinsic GTPase activity of 
MeaB while disrupting its activation by MCM. We also report the structure of MeaB crystallized 
in the presence of GDP and AlF4-. Our results suggest a strategy for switch II-dependent auto-
inhibition of the intrinsic GTPase activity of MeaB, which exists predominantly in an inactive 
conformation. Complexation with MCM is predicted to switch the MeaB conformation thereby 
activating its GTPase function.  
 
4.3 Methods and Materials 
 
4.3.1 Materials-AdoCbl, 5´-guanylyl-β,γ-imidophosphate (GMPPNP), ATP, GTP, 
methylmalonic acid, coenzyme-A, and other reagent grade chemicals were purchased from 
Sigma. Trifluoroacetic acid was purchased from Aldrich. Methylmalonyl-CoA was synthesized 
using malonyl-CoA synthetase, purified as described previously (37). The HPLC column used to 
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quantify guanosine nucleotides was a µBondapakTM NH2 10 µm, 125 Å 3.9 x 300 mm column 
purchased from Waters. 
4.3.2 Construction of site-specific mutants–Plasmids encoding the M. extorquens ATR and 
MCM were generous gifts from Mary E. Lidstrom (University of Washington, Seattle). A 
synthetic gene encoding M. extorquens AM1 MeaB with 5´-Nco1 and 3´-Xho1 restriction sites 
was generated by GenScript Corporation (New Jersey, USA) to optimize codon usage in E. coli 
and reduce the GC content. The synthetic MeaB gene was cloned into the pET-21d(+) expression 
vector (Novagen, Gibbstown, NJ) using the Nco1 and Xho1 sites. Site-specific mutants of MeaB 
were generated using a Quickchange kit (Agilent, Santa Clara, CA) according to the 
manufacturers protocol. The following forward primers were used to generate the mutants and 
the reverse primers had the complimentary sequences. 
E154A: 5´-CGATGTCATTCTGGTGGCAACC GTTGGCGTCGGTCAGAGCG-3´ 
T155A: 5´-CGATGTCATTCTGGTGGCAAGCC GTTGTTGGCGTCGGTCAGAGCG-3´ 
Q160A:5´-GGAAACCGTTGGCGTCGGTGCGA GCGAAACCGCCGTTGC-3´ 
S161A: 5´- GGAAACCGTTGGCGTCGGTCAG GCCGAAACCGCCGTTGGCAG-3´ 
E162A: 5´-CCGTTGGCGTCGGTCAGAGCGCA ACCGCCGTTGGCAGATCTG-3´ 
Following sequence confirmation, the Q160A plasmid and E162A primer pair were used to 
generate the Q160A/E162A double mutant. 
4.3.3 Enzyme Expression and Purification–Recombinant M. extorquens MeaB, MCM, and 
ATR were expressed and purified from E. coli BL-21 (DE3) as described previously (4,38). The 
purified enzymes were flash frozen in liquid nitrogen and stored at -80 °C in 50 mM HEPES 
buffer, pH 8.0, containing 0.3 M KCl, 10 mM MgCl2, 10% glycerol (Buffer A). 
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4.3.4 Crystallization of MeaB-Protein samples were concentrated to 11 mg ml-1 in 50 mM 
HEPES buffer at pH 8.0, 2.5 mM MgCl2, 5 mM GDP, 1 mM [AlF4]-. MeaB:GDP•AlF4- crystals 
were grown by the sitting drop vapor diffusion method at 20 ºC by mixing 2 µL of protein 
solution with 2 µL of reservoir solution. The reservoir solution contained 20 % (w/v) PEG3350, 
and 0.2 M sodium sulfate. Crystals were cryoprotected for a few minutes before being flash 
frozen in liquid N2, by transfer to a solution of 20% glycerol, 15% (w/v) PEG3350, 0.15 M 
sodium sulfate, 5 mM GDP, and 1 mM [AlF4]- in 25 mM HEPES, pH 7.5. Crystals of 
MeaB:GDP•AlF4- were of space group P21 (a= 63.7, b= 78.6, c= 69.6, β= 108.6) with 2 
monomers in the a.u. 
4.3.5 Data collection and structure determination–Diffraction data for MeaB:GDP•AlF4- were 
collected at 100 K on beamline GM/CA-CAT 23-ID-B at the Advanced Photon Source, Argonne 
National Laboratory (Argonne, IL). Data were recorded on a Mar300 detector and processed 
with XDS (39) to 1.8 Å resolution (Table 1). EPMR (40) was used to determine initial phases for 
the MeaB:GDP•AlF4- through molecular replacement using a single monomer of the MeaB:GDP 
structure (PDB ID 2QM7 (26)) as a search model. Loops containing residues 62-67, 95-100, 
181-186, and 225-231 were removed from the search model to eliminate bias. Initial density 
allowed for ligand to be modeled and added. REFMAC (41) of the CCP4 suite (42) was 
subsequently employed for restrained refinement of the model using isotropic individual B-
factors to a final Rwork of 0.190 and Rfree of 0.236. Model building and modification was 
performed with Coot (43), and the geometric quality of the models and their agreement with the 
structure factors were assessed with MolProbity (44). Crystallographic information as well as 
refinement statistics are provided in Table 1. Figures were generated with PyMOL (45). 
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4.3.6 Thermodynamics of GMPPNP-binding–Isothermal titration calorimetry (ITC) 
experiments were performed at 10 °C in Buffer A using a 300 µl injection syringe and a 1.43 ml 
injection cell. Samples were prepared by filtration through a 0.2 µm filter and then degassed 
under vacuum at 4 °C using a ThermoVac sample degasser. Each titration was performed at least 
in duplicate. GMPPNP (10 µl injections of 150-400 µM) was added to 10-25 µM MeaB. The 
data were analyzed using a two-site binding model using the MicroCal ORIGIN program. Values 
for the dissociation constant at sites 1 and 2 were then compared to the values obtained from the 
solution of the Gibbs free energy equation ΔGo = -RTln(KA). 
4.3.7 Enzyme Inactivation Assays–Inactivation of MCM during steady-state was examined by 
enzyme-monitored turnover using UV/visible spectroscopy to follow the conversion of MCM-
bound cob(II)alamin to aquocob(III)alamin (H2OCbl) at 20 °C in 0.1 M potassium phosphate at 
pH 7.5 containing 10 mM MgCl2. The reactions and sample preparations were performed in the 
dark to avert spurious H2OCbl formation by photolysis of AdoCbl. Samples were prepared by 
the addition of reaction components in the order described below. MCM (25-30 µM) was 
reconstituted with an equimolar concentration AdoCbl. 35-40 µM of MeaB was added to the 
MCM holoenzyme to generate and fully populate the 1:1 MCM:MeaB complex. GMPPNP was 
then added to the reaction mixtures to a final concentration of 1-2 mM. The reaction was 
initiated by the addition of methylmalonly-CoA to a final concentration of 4.5-5 mM. The rates 
of inactivation were determined by plotting the change in absorbance at 351 nm, corresponding 
to H2OCbl formation, as a function of time. The kinetic traces were best fit by a single 
exponential equation: ΔAt = Ao – ΔApe(-kt), where ΔAt is the absorbance at 351 nm as a function 
of time, Ao is the initial absorbance of cob(II)alamin, ΔAp is the reaction phase amplitude for 
OHCbl formation, and k is the observed rate constant for MCM inactivation. 
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4.3.8 Assay for transfer of AdoCbl from ATR to MCM–The ATP-dependent transfer of 
AdoCbl from ATR to the MCM:MeaBGMPPNP complex was performed in the dark at 20 °C 
and monitored by UV/visible spectroscopy. Two equivalents of AdoCbl were added to one 
equivalent of ATR in Buffer A to generate holo-ATR. The apo-MCM:MeaBGMPPNP complex 
was reconstituted in Buffer A by mixing 40-50 µM apo-MCM with an equimolar concentration 
of AdoCbl and 50-60 µM of MeaB to give 40-50 µM of the complex. GMPPNP was added to a 
final concentration of 1 mM. Holo-ATR (2:1 AdoCbl:ATR) and the MCM:MeaBGMPPNP 
complex (40-50 µM) were mixed and incubated for 10 min at 20 °C before that addition of ATP 
to a final concentration of 5 mM. Release/transfer of AdoCbl from ATR was calculated using a 
Δε525 = 6.69 mM-1cm-1. Bound versus free cofactor was separated using an Amicon centrifuge 
filter (10 kDa cutoff, 20 min, 4 °C, 16,000 x g). The concentration of free AdoCbl in the filtrate 
was calculated using ε525 = 8.0 mM-1cm-1. 
4.3.9 Release of Cob(II)alamin–MCM (30-40 µM) was mixed with 45-60 µM of wild-type, 
E154A, T155A, Q160A, S161A, E162A, or Q160A/E162A MeaB in Buffer A such that 
[MCM]:[MeaB] was 1:1.5 at 20 °C and under strictly anaerobic. Cob(II)alamin was generated by 
reduction of H2OCbl with tris (2-carboxyethyl) phosphine hydrochloride (TCEP) and  was added 
to a final concentration equal to that of the MCM:MeaB (wild-type or mutant) complex. The 
reaction mixture was incubated for 10 min at 20 °C. GMPPNP in anaerobic Buffer A was added 
to a final concentration of 2 mM. The mixture was then incubated for 20 min at 20 °C. 
Subsequently, the sample was made aerobic by air oxidation for 2 h and then filtered through to a 
Centricon YM10 filter (10 kDa cutoff) to separate free from bound H2OCbl. Cob(II)alamin (but 
not H2OCbl) can be released from MCM and is subsequently oxidized to H2OCbl, which was 
quantified using ε350 = 9.3 mM-1cm-1. 
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4.3.10 GTPase activity of MeaB–The GTPase activity of MeaB was determined using an HPLC 
assay as described previously (46). 
4.3.11 Size-Exclusion Chromatography–Samples were prepared in Buffer A containing 0.5 
mM GDP and 80-90 µM of wild-type or mutant MeaB ± equimolar MCM and 0.5 mM AdoCbl 
in a total volume of 150 µl, was prepared in the dark and loaded onto A Superdex-200 HR 10/30 
column equilibrated with Buffer A. The protein complexes were eluted in the dark to minimize 




4.4.1 Structural characterization of MeaB:GDP•AlF4- 
MeaB was crystallized in the presence of GDP•AlF4-, a potential transition state mimic. All the 
crystals were treated with a cryoprotectant solution containing an excess of GDP and AlF4-. 
MeaB crystallizes in the presence of GDP and AlF4- in the P21 space group, and a unit cell 
similar to that reported for MeaB crystallized in the presence of GDP (Table 4.1). However, 
AlF4- was not observed in any of the more than ten structures that were solved. Furthermore, 
despite inclusion of Mg2+ in the crystallization conditions it was also not observed in the crystal 
structure of MeaB. Although the structures of MeaB crystallized in the presence of GDP and 
AlF4- (MeaBGDP•AlF4-) appears to be identical to that of MeaBGDP (Fig. 4.2a), closer 
inspection revealed two significant differences as described below. 
 Superposition of the MeaBGDP(+AlF4-) and MeaB•GDP structures (Fig. 4.2a) yielded 
rmsd values of 2.31 Å for the Cα atoms of all residues, suggesting the two structures were 
similar in their overall tertiary and dimeric structure. Superimposition of the MeaB dimers and 
alignment with respect to the nucleotides, revealed no differences in the nucleotide binding sites 
between the MeaB•GDP and MeaBGDP(+AlF4-) structures. However, R108 in the MeaBGDP 
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structure (Fig. 4.2b, yellow) is solvent exposed and facing away from the active site cavity. In 
contrast, R108 is swung toward the β-phosphate group of GDP and engages in a salt bridge 
contact with the carboxylate of E154 in the structure of MeaB•GDP(+AlF4-) (Fig. 4.2b, blue). To 
assess whether the observed structural differences were due to the slightly different 
crystallization conditions, the structure of MeaB in the presence of GDP was re-determined 
under conditions used to obtain the MeaB•GDP(+AlF4-) structure. The new and published (PDB 
ID 2QM7) structures of MeaB•GDP were found to be identical (data not shown). 
 
Table 4.1 MeaBGDP(+AlF4-) Structure and Refinement Statistics. Statistics for the highest 
resolution shell are enclosed in parentheses. b Rsym = ∑|I – <I>|/∑I, where I = observed intensity, 
and <I> = average intensity obtained from multiple measurements. c Rcryst = ∑||Fobs|–
|Fcalc||/∑|Fobs|, where Fcalc and Fobs are the calculated and observed structure factor amplitudes, 
respectively. d Rfree, R-factor based on 5% of the data excluded from refinement. e RMSD, root 






Figure 4.2. Comparison of the MeaBGDP(+AlF4-), MeaBGDP, and MeaBGMPPNP 
structures. a) Structural superposition of the MeaBGDP(+AlF4-) (dark grey, unpublished) and 
MeaBGDP (light grey, PDB 2QM7) structures. GDP from the MeaBGDP(AlF4-) structure is 
shown in sphere representation in dark blue. Switch motifs I, II, and III are colored blue, red, and 
cyan, respectively. b) Comparison of the l orientations and interactions of switch I and II in the 
structures of MeaBGDP(+AlF4-)  (blue) and MeaBGDP (yellow). GDP and amino acid 
residues are shown in sticks representation and dashed lines represent hydrogen bonding or ionic 
interactions. c) Comparison of the interactions between switch II and switch III in the structures 
of MeaBGDP(+AlF4-) (blue), MeaBGDP (yellow), and MeaBGMPPNP (grey, PDB 4JYC). 
K188 in the MeaBGDP(+AlF4-) is shown in two conformations based on the electron density. d) 
Superposition of MeaBGDP(+AlF4-) (blue) and MeaBGDP (yellow) and a close-up of the 
interactions of switch III residues with the flexible loop on the adjacent subunit (224-232). 
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 Additional differences between the MeaBGDP(+AlF4-) and MeaB•GDP structures are 
observed in the Switch III region (residues 178-188) and its interaction with conserved residues 
Q160 and E162 in switch II (Fig. 4.2c).  In the structure of MeaBGDP(+AlF4-), the side chain of 
Q160 is swung ~25° from its position in the MeaBGDP structure (Fig. 4.2c, blue). The electron 
density for the side chain of K188 allows it to be modeled in two configurations. In one 
configuration, K188 contacts switch II via an ionic interaction with the carboxylate of E162 and 
a single hydrogen bond with the carbonyl oxygen of G159. In the other configuration, the 
interactions between K188 and switch II are disrupted. In contrast, hydrogen bond contacts 
between K188 of switch III and E162, or any other part of switch II, are not observed in the 
MeaBGDP structure (Fig. 4.2c, yellow). The contacts formed between switch II and III in the 
MeaBGDP(+AlF4-) structure are also distinct from those captured in the structure of 
MeaBGMPPNP. In the MeaBGMPPNP structure, the side chain of K188 is ion paired to the 
carboxylate of E162 and engaged in a hydrogen bonding contact with the amide side chain of 
Q160 (Fig. 4.2c, grey).  
 The MeaBGDP(+AlF4-) and MeaBGDP structures also differ in the interaction of the 
Switch III region with a flexible loop from the adjacent monomer extending between residues 
224-232. In one of the monomers of the MeaBGDP(+AlF4-)  structure, the backbone carbonyl 
oxygen of E183 is hydrogen bonded to S230 (Fig. 4.2d, blue). In contrast, the conformation of 
switch III in the MeaBGDP structure precludes E183 from contacting the 224-232 loop (Fig. 
4.2d, yellow). The only contact formed between Switch III and the 224-232 loop in the 
MeaBGDP structure is a single hydrogen bond between the side chain of H224 and the 
carboxylate of residue D182. At the same subunit interface of the MeaBGDP(+AlF4-)  structure, 
D182 is disordered. D182 in the opposing subunit interface of MeaBGDP(+AlF4-)  structure 
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does not engage in hydrogen bonding with the 224-232 loop, and is displaced ~9 Å compared to 
the position of D182 at the same subunit interface in the MeaBGDP structure. In both 
MeaBGDP and MeaBGDP(+AlF4) structures, T232 is hydrogen bonded to the carboxylate of 
E267 in helix α11 within the same subunit.  
4.4.2 Effect of switch II mutations on MCM:MeaB complex formation 
ITC analysis of the binding affinities between MCM and MeaB mutants E154A, T155A, and 
Q160A revealed that the switch II mutants bind MCM similarly to wild-type MeaB (data not 
shown). Alternatively, complex formation between MCM and these MeaB mutants, as well as 
the S161, E162A, and Q160A/E162A MeaB, was also established by gel filtration 
chromatography. Reconstituting the MCM and wild-type or mutant MeaB complex by 
combining a 1:1 molar ratio of each protein in the presence of a molar excess of GDP and 
AdoCbl demonstrated that each MeaB mutant formed a complex with MCM. Wild-type and 
mutant MeaBs and MCM migrated with molecular masses of 68 and 142 kDa, respectively 
consistent with their calculated masses. With each MeaB mutant, formation of an MCM:MeaB 
complex with a molecular mass of 243 kDa was observed, consistent with the formation of a 1:1 
complex between the two proteins (data not shown). 
4.4.3 GMPPNP binding to switch II MeaB mutants 
The MeaB homodimer binds nucleotides with negative cooperativity (Table 4.2). GMPPNP 
binds to sites 1 and 2 with KD values of 0.8 ± 0.4 µM and 9.5 ± 1.9 µM, respectively. The KD 
values for GMPPNP binding at site 1 range from 0.16 ± 0.01 to 1.29 ± 0.31 µM and from 0.48 ± 
0.07 to 9.6 ± 1.4 µM at site 2. Overall, the switch II mutations do not have a substantial impact 
on GMPPNP binding, with the exception of the E162A and Q160A/E162A double mutants in 
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which the affinity for the nucleotide increases ~20-fold. GMPPNP binds to each switch II mutant 
with negative cooperativity. 
4.4.4 GTPase activity of switch II mutants 
 The intrinsic and GAP-stimulated GTPase activities of the single and double switch II 
mutants were compared to wild-type MeaB (Table 4.3). Surprisingly, the E154A and Q160A 
mutants exhibited an ~10-fold activation of the intrinsic GTPase activity compared to wild-type 
MeaB. Furthermore, compared to the ~100-fold rate enhancement observed with wild-type 
MeaB, the GAP function of MCM was less in the MCM:MeaB complex formed by either of the 
E154A or Q160A mutants. The T155A, S161A, E162A, and Q160A/E162A mutations had a 
modest impact on the intrinsic GTPase rate and two (T155A and S161A) exhibited mild 
impairment GAP activation.  
Enzyme KD (µM) 
 Site 1  Site 2 
Wild-typea 0.81 ± 0.50  9.53 ± 1.91 
E154A 1.29 ± 0.31  9.60 ± 1.42 
T155A 0.47 ± 0.17  3.66 ± 0.46 
Q160A 0.73 ± 0.11  3.32 ± 0.58 
S161A 1.11 ± 0.29  3.88 ± 0.77 
E162A 0.04 ± 0.02  0.60 ± 0.12 
Q160A/E162A 0.16 ± 0.01  0.48 ± 0.07 
 
Table 4.2. Thermodynamic data for GMMPNP-binding to MeaB. aDetermined previously 
(46). 
Enzyme kcat (min-1)   
 - MCM  + MCM  Fold GAP-Activation 
Wild-typea 0.039 ± 0.003  4.08 ± 0.20  102.0 
E154A 0.335 ± 0.018  0.52 ± 0.11  1.6 
T155A 0.091 ± 0.014  2.84 ± 0.31  31.1 
Q160A 0.470 ± 0.013  0.54 ± 0.06  1.2 
S161A 0.027 ± 0.006  2.35 ± 0.20  87.0 
E162A 0.017 ± 0.006  1.07 ± 0.09  62.9 
Q160A/E162A 0.018 ± 0.002  0.12 ± 0.02  6.7 
 





4.4.5 Switch II mutations affect the rate of oxidative inactivation of MCM 
In the presence of wild-type apo-MeaB, the rate of oxidative inactivation of MCM is 8.8 x 
10-3 min-1 (Fig. 4.3a, trace 1). Addition of GMPPNP or GDP to the wild-type MCM:MeaB 
complex decreases the inactivation rate nearly 30-fold (3.0 x 10-4 min-1, trace 2) (2). While the 
Q160A (2.8 x 10-4 min-1, trace 3) and E162A (2.8 x 10-4 min-1, trace 4) mutants do not 
appreciably impact the rate of MCM inactivation, E154A (2.0 x 10-4 min-1, trace 5) and 
Q160A/E162A (2.1 x 10-4 min-1, trace 6) lead to enhanced protection. The S161A (4.4 x 10-4 
min-1, trace 7) and T155A (6.8 x 10-4 min-1, trace 8) mutations exhibit 1.5- and 2.3-fold higher 
rates of inactivation than wild-type MeaB.  
4.4.6 Impaired GTPase-dependent AdoCbl transfer from ATR to MCM by switch II 
mutants 
The M. extorquens ATR binds two equivalents of AdoCbl per homotrimer and binding of 
ATP to the vacant site initiates the transfer of a single equivalent of AdoCbl to the MCM:MeaB 
complex (3). In the presence of GMPPNP, transfer of AdoCbl to the wild-type MCM:MeaB 
complex is blocked. Instead, one equivalent of the cofactor is released from ATR into solution 
(Fig. 4.3b). With GMPPNP bound to the MCM:E154A MeaB mutant complex, AdoCbl transfer 
becomes modestly uncoupled from nucleotide hydrolysis (0.82 equivalents released and 0.18 
equivalents transferred). Cofactor transfer is more significantly impaired to the complexes of 
MCM and T155A, Q160A, S161A, or E162A MeaB with GMPPNP bound (0.46–0.52 
equivalents of AdoCbl transferred). The Q160A/E162A double severely impacted GTPase gating 




4.4.7 Rescue of MCM by switch II mutants 
Our previous studies have shown that MeaB promotes expulsion of cob(II)alamin that has 
become uncoupled from 5´-deoxyadenosine during turnover in MCM (3). Here, we have 
examined the role of switch II in exerting this MeaB function of MeaB. In the presence of 
stoichiometric cob(II)alamin (with respect to MCM) and an excess of each switch II mutant 
MeaB, cob(II)alamin remains bound to MCM. Following addition of an excess of GMPPNP to 
the wild-type MeaB:MCMcob(II)alamin complex, ~97% of the inactive cob(II)alamin is 
detected in the filtrate, indicating that the inactive cofactor was ejected from the MCM active site 
(Fig. 4.3c). In contrast, in the presence of the MeaB mutants E154A, T155A, Q160A or S161A, 
only ~35-45% of cob(II)alamin was ejected while the remainder was associated with MCM. In 
the complex of MCM:MeaB harboring the E162A single or the Q160A/E162A double 




 While the roles of switch motifs in the catalytic and signaling mechanisms of many G-protein 
have been studied quite extensively (13,19,20,47,48), their role in cofactor delivery is not as well 
characterized.. Unlike the structures of CooC and NifH, the crystal structures of MeaB in the 
apo-, Pi, GMPPNP, and GDP (crystallized in the presence and absence of AlF4-) have failed to 
capture a catalytically active GTPase conformation. This is paralleled by the absence of Mg2+ in 
the active site of all available MeaB crystal structures, raising questions about the possible 
significance of the inactive conformation to MeaB function. In this study, we have examined the 
role of the conserved switch II residues in suppressing the intrinsic GTPase activity MeaB in the 
absence of MCM.  
 98 
In HypB and other G3E GTPases, the general base is a conserved aspartate residue (D69 in 
HypB, Fig. 4.1b) positioned N-terminal to switch I following the second β- sheet (25). The 
structure of HypBGTPγS shows D69 positioned ~5-6 Å from the γ-phosphinothioyl group of 
GTPγS and interacting with water molecules, one of which serves presumably serves as the 
nucleophile. The residue corresponding to D69 in HypB is D92 in MeaB. The MeaB structures 
containing GDP(+AlF4-) or GMPPNP, demonstrate how the hydrophobic side chains Val156 and 
Val158 impede access of D92 to the nucleotide (Figs. 4.4a-c). We speculate that the interaction 
between E154 and R108 is important for maintaining an auto-inhibitory conformation in MeaB 
that is alleviated in the MCM:MeaB complex. This model is consistent with the ~10-fold 
increase in the intrinsic GTPase activity of the E154A mutant and its relative insensitivity to 
GAP activity of MCM. E154A might be important for Mg2+ binding in the MCM:MeaB 
complex. 
The similar effect of the E154A and Q160A mutants on the intrinsic and GAP-stimulated 
GTPase activities is surprising (Table 4.3). Q160 is not positioned near the active site in any of 
the MeaB structures and is not conserved in other G3E GTPases and is not predicted to directly 
participate in catalysis. Q160 engages in various hydrogen bonding interactions with residues in 
switch II, switch III and a conserved threonine immediately C-terminal to switch II in different 
MeaB structures (Fig. 4.5). Q160 forms a direct or water-mediated hydrogen bond with E161, 
E162 T163 or K188. In contrast, Q160 is not engaged in hydrogen bonding interactions in a 
couple of MeaB structures e.g. MeaBGDP and in apo-MeaB. Hence, while our kinetic data 
suggest that Q160 is important for auto-inhibition, the structures of MeaB do not provide insights 
into a possible mechanism. The inability of the S161 and E162 mutations to mirror the Q160 
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phenotype suggests that the individual disruption of their interaction with Q160 is insufficient to 
disrupt the auto-inhibited conformation of MeaB. 
The switch II residues T155, S161, and E162, are not conserved among G3E GTPases. 
Furthermore, obvious roles for T155, S161 and E162 in GTP binding or in the GTPase reaction 
are not apparent from the various MeaB structures. Both the T155A and S161A mutations result 
in a modest perturbations to the GTPase activity of isolated MeaB and in the MCM:MeaB 
complex (Table 4.3). These data indicate that neither T155 nor S161 plays an important role in 
auto-inhibition. In contrast, E162 significantly decreases the affinity of isolated MeaB for GTP at 
both sites 1 and 2 (Table 4.2). E162 might exert its effect on auto-inhibition of the intrinsic 
GTPase activity via reduced affinity for the substrate, GTP. 
Many G-proteins use an octahedrally coordinated Mg2+ to stabilize the transition state and a 
general base to activate the nucleophilic water (23,25). In HypB from Methanocaldococcus 
jannaschii, E120 in the ExxG switch II motif directly ligates the active site Mg2+. The 
corresponding residue in MeaB is E154. In all MeaB structures with the exception of 
MeaBGDP (PDB 2QM7), E154 interacts with neighboring residues e.g. K68 from the P-loop 
and R108 in switch I (Figs. 4.4a and 4.4c). Some/all of these interactions are expected to be 




Figure 4.3. Impact of switch II mutations on the chaperone functions of MeaB. a) Time-
dependent inactivation of MCM in complex with wild-type mutant MeaB•GMPPNP. The data 
presented here are representative of ≥2 experiments and were fit to a single exponential equation 
described under Experimental Procedures. b) ATP-dependent AdoCbl release or transfer from 
holo-ATR to the MCM:MeaB complex (containing wild-type or switch II mutant MeaBs) in the 
presence of GMPPNP. The data were averaged from ≥2 independent experiments. c) 
Displacement of cob(II)alamin from MCMcob(II)alamin:MeaB (wild-type or switch II mutants) 




















































































































Figure 4.4. Comparison of MeaBnucleotide structures. a) MeaBGDP(+AlF4-), b) 
MeaBGDP, and c) MeaBGMPPNP. Bound nucleotide and amino acid side chains are shown in 





























 We have speculated that switches II and III communicate during bidirectional signal 
transmission between MeaB and MCM. K188 in switch III and E162 and Q160 in switch II 
might be important for relaying information about nucleotide identity and hydrolysis between 
these switch motifs (Fig. 4.2b). A mutation in CblA corresponding to the K188 residue in MeaB 
is pathogenic (49). We have shown that mutation of K188 has pleiotropic consequences 
including loss of regulated GTPase depdendent AdoCbl loading into MCM and impaired repair 
of inactive MCM. In this study, we demonstrate that mutation of the interacting residues Q160 
and E162 partially uncouples cofactor docking in MCM from GTP hydrolysis in MeaB (Fig. 
4.3b) and ejection of inactive cofactor from MCM (Fig. 4.3c). The Q160A/E162A double mutant 
is more impaired than either single mutant and more closely resembles the phenotype of the 
K188 mutant. Similar perturbations in MeaB function, albeit of of varying magnitude, are also 
observed with other switch II mutants, consistent with a role for motif in signaling between 
MeaB and MCM via switch III. 
 G-proteins are engaged in a diverse array of regulatory processes (21,50,51). They are among 
the most common and ancient regulatory proteins in Nature (13). An increasing body of evidence 
is demonstrating significant variations in the mechanisms of and factors employed for GTP 
hydrolysis and signal transduction, which are not readily predicted by sequence and structural 
homology (52). For instance, MeaB appears to deploy a its putative catalytic motifs, switch I and 
II, for catalysis in the MCM:MeaB complex and for auto-inhibition of GTPase activity in 





Figure 4.5. Conformations of Q160 in MeaB structures. The structures of (a) 
MeaBGMPPNP (grey), (b) MeaBGDP(AlF4-) (blue), (c) MeaBGDP (yellow), (d)MeaBPPPi 
(green), and (e) apo-MeaB (cyan) are shown and were generated from PDB files 4JYB, 
unpublished (MeaBGDP(AlF4-), 2QM8, and 4JYC, respectively. Adjacent subunits of the 
MeaB homodimers from individual crystal structures are shown for comparison. Individual 
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SIGNAL TRANSDUCTION AND CATALYSIS VIA SWITCH I, A CANONICAL SIGNALING 
MOTIF IN MEAB9,10 
 
5.1 Abstract 
MeaB and its human ortholog CblA, are G-proteins that function as chaperones for docking 
AdoCbl into the active site of B12-dependent MCM. Both proteins also safeguard their cognate 
MCMs against inactivation. In addition, MeaB functions as a reactivase for MCM by eliciting 
the ejection of inactivated cofactor generated adventitiously during turnover. Conserved motifs 
known as switch I and II are present in both MeaB and CblA and are predicted to communicate 
with MCM via conformational changes in response to nucleotide binding and hydrolysis. Both 
proteins possess an additional motif, switch III, whose involvement in bidirectional signaling 
between the MCM and MeaB active sites supports the GAP function of MCM and the chaperone 
function of MeaB. In this study, we have used alanine-substitution mutagenesis of conserved 
residues in switch I to gain insight into the function of this canonical signaling motif in catalysis 
and signal transduction. Our results suggest that the chemical mechanism of GTP hydrolysis by 
                                                
9The content of this chapter has been prepared for submission to the J. Biol Chem.: Lofgren, M. and Banerjee, R. 
“Signal Transduction and Catalysis via Switch I, a Canonical Signaling Motif in the Radical B12 Protein Chaperone, 
MeaB”. 
 




MeaB alone might differ from that utilized in the activated MCM:MeaB complex. We also 
provide evidence that a single switch I arginine residue is essential for nucleotide binding by 
MeaB. Finally, we demonstrate that mutations at conserved positions in the switch I sequence of 
MeaB disrupts the chaperone functions of MeaB, as well as the GAP functions of MCM. Our 
results reveal that switch I, II and III motifs of MeaB are each involved in multiple chaperone 
functions, with switch I and II likely involved in controlling and catalyzing the GTPase reaction. 
5.2 Introduction 
MeaB from Methylobacterium extorquens is a member of the SIMIBI [signal recognition 
particle (SRP), MinD, and BioD-related] class of G-proteins and functions as a chaperone for 
MCM (1-4). The latter belongs to the family of B12-dependent isomerases that use AdoCbl as a 
cofactor (5,6). MCM is a mitochondrial protein in humans and participates in the catabolism of 
branched-chain amino acids, odd-chained fatty acids, and cholesterol by catalyzing a 1,2-carbon 
skeleton isomerization reaction. The tissue concentration of cobalamins is low in mammals and 
formation of the MCM holoenzyme is reliant upon an auxiliary pathway for assimilation and 
post-translational insertion of AdoCbl (7-9). In humans, mutations in auxiliary proteins in the 
assimilation and in AdoCbl trafficking pathways result in diminished MCM activity and lead to 
methylmalonic acidemia (10-14). Since catalysis by MCM involves homolysis and geminal 
recombination of the cobalt-carbon bond in AdoCbl, inadvertent dissociation of deoxyadenosine 
from the active site during turnover is another source of impairment of MCM activity. Current 
evidence suggests that MeaB and CblA control the loading of AdoCbl into the MCM active site, 
and protect MCM from inactivation during steady-state turnover (3,4,15-17).  
Other SIMIBI metallochaperones include UreG, CooC and HypB (1) that catalyze the 
insertion of Ni2+ into urease (UreG), CO dehydrogenase (CooC), and [Ni-Fe]-hydrogenase 
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(HypB), respectively (19-24). CooC and HypB undergo NTP-dependent dimerization, which is 
required for their control over the transfer of Ni2+ to their respective client proteins (24-27). In 
contrast, MeaB exists as dimer, binds MCM tightly, and does not bind AdoCbl directly. Rather, 
ATR synthesizes and delivers AdoCbl to MCM via a mechanism that is proposed to be 
allosterically gated by binding of ATP to ATR and by GTP hydrolysis by MeaB (Fig. 5.1) (3).  
G-proteins are identified by a minimum of four sequence elements known as G binding 
motifs (G1-G4) (18). The G1 motif is commonly known as Walker A or the phosphate-binding 
loop (P-loop) and recognizes the triphosphate handle of GTP. In MeaB, the P-loop spans 
residues 62-70 and has a GxxGxGKST consensus sequence (28). The G2 and G3 elements are 
the switch I and II motifs, respectively. In most G-proteins, switch I and II are involved in 
catalysis and signaling to downstream effector proteins (1,18,29). Residues in switch I and II 
provide some of the ligands to the Mg2+ ion and undergo conformational rearrangements in 
response to nucleotide binding, exchange and hydrolysis. In this “loaded spring” mechanism, 
direct, H2O-mediated or Mg2+-mediated contacts between switch motif residues and the γ-
phosphate of GTP are made upon its binding and are disrupted upon its hydrolysis (30). 
However, the signaling and catalytic conformations of switch I and II in MeaB await elucidation, 
as residues in switch I and II that are predicted to be critical for nucleotide binding and catalysis 
are significantly retracted from the predicted active site in the various MeaB structures. Hence, 
based on the crystal structures of HypBGTPγS, crystallographic studies of MeaB with bound 
nucleotides appear to have failed to capture switch I and II in an active conformation (24). 
Additionally, the structures of MeaB with bound nucleotides demonstrate that the active site 
lacks residues predicted to be important in catalysis. Finally, a base-specificity loop (G4), whose 
consensus sequence is NKxD in MeaB, selectively recognizes the guanine nucleobase.  
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Most isolated G-proteins are innately slow at catalyzing GTP hydrolysis (18). The cognate 
mutases of MeaB and CblA, the human ortholog of MeaB, function as GAPs and accelerate the 
rate of GTP hydrolysis (4,16). Typically, proteins with GAP functions elicit G-protein activation 
by interfacing with the partner G-protein to provide residues that complete the active site. In 
many GTPases, an active site aspartate, glutamine, asparagine, or histidine residue, often 
provided by switch I or II, is required for stabilization or polarization of an active site water 
molecule for nucleophilic attack of the γ-phosphate (24, 31-33). Typically, an active site arginine 
residue referred to as an arginine “finger” neutralizes the developing negative charge in the 
transition state (34-36). In principle, the residues involved in polarization of water in the active 
site to increase its nucleophilicity and charge stabilization in the transition state can be derived 
from the G-protein or from its GAP. The α subunits (Gα) of heterotrimeric G-proteins contain 
catalytic arginine and asparagine residues that are provided by the G-protein (37,38). In contrast, 
the active site of the Ras:Ras-GAP complex contains an asparagine from Ras and an arginine 
from Ras-Gap (36). In Rab33, the asparagine from the G-protein is replaced by an asparagine 
residue (an asparagine “thumb”) from Rab-GAP, which also supplies the catalytic arginine 
residue (39). Thus, GAPs function by providing their G-proteins with active site residues or by 
stabilizing the catalytic machinery that is provided by the G-protein. One or both of these 
strategies may be employed by MCM proteins for acceleration of the GTP hydrolysis in CblA 
and MeaB.  
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Figure 5.1. Cartoon representation of the nucleotide-dependent control of AdoCbl transfer 
from ATR (blue) to MCM (green) in the MCM:MeaB (yellow) complex. MeaB with bound 
nucleotides are shown in yellow. Cobalamin is shown as a red oval. The transfer of AdoCbl from 
ATR to MCM occurs upon binding of ATP to ATR and requires hydrolysis of GTP to GDP on 
MeaB. AdoCbl switches from a 5-coordinate “base-off” conformation in ATR to a 6-coordinate 
“base-off/His-on” conformation in MCM. 
 
The minimal consensus sequence in the switch II region of MeaB and other G3E proteins is 
ExxG (where x denotes any amino acid) (1). Based on the structure of HypBGTPγS, the leading 
glutamate residue in the MeaB switch II sequence is E154 and therefore, it is predicted to ligate 
Mg2+ directly (Fig. 5.2) (24,28). However, Mg2+ is not present in any of the currently available 
crystal structures of MeaB.  Recent biochemical evidence supports a role for E154 in the 
stabilization of an auto-inhibited conformation of MeaB, perhaps via its interaction with a 
conserved R108 residue in switch I. In Ras G-proteins, a conserved glutamine residue 
immediately following the ExxG sequence, polarizes a catalytic water molecule for nucleophilic 
attack on the γ-phosphate of GTP (32,40). In most G3E GTPases, a hydrophobic residue 
substitutes for glutamine (1) and a strongly conserved aspartate residue (Aspcat) at the N-
terminus of the switch I motif is proposed to serve as the general base for activation of water 










However, in the available MeaB crystal structures, D92 is not positioned for catalysis and is 
blocked from the active site by the switch II loop, particularly the hydrophobic side chain of 
residue V156.  
 
 
Figure 5.2. Comparison of the enzyme active sites of MeaB and HypB from the crystal 
structures of a) MeaBGMPPNP (PDB 4JYC) and of b) HypBGTPγS (PDB 2HF8). 
Shown in stick representation are the bound guanosine nucleotides (blue), conserved residues in 
switch I (yellow), and residues contributed from the adjacent subunit in the structure of 
HypBGTPγS (orange). Residue V156 in switch II is shown as Van der waals spheres. C) The 
table lists the conserved switch I and II sequences in HypB and MeaB, and their proposed 
functions.  
 
The switch I sequence is conserved between MeaB and its orthologs (12,28,43). Among 
various families of G-proteins, the boundaries, lengths, and amino acid sequences of the switch I 
motif varies considerably, and must be empirically defined for each subfamily (1,30). The switch 
I region in the Ras family of G-proteins has only a single threonine residue that is strongly 
conserved, and it positions switch I via main-chain hydrogen bond interactions to the γ-
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phosphate of GTP (44,45). In HypBGTPγS, D75, which is strongly conserved in the G3E 
proteins, replaces that threonine residue and engages in water-mediated and direct interactions 
with the Mg2+ ion (Fig. 5.2) (24). In MeaB and CblA, switch I is on an extended loop with the 
consensus sequence DPSSxx[S/T]GGShLGDKTR (residues 92–108 in MeaB; x and h represent 
any and  hydrophobic amino acids, respectively) (12,16,28). The residue equivalent to D75 in 
HypB is D105 in MeaB. However, D105 is not located in the active site in any of the MeaB 
crystal structures, which has precluded the functional assignment for this conserved residue 
(28,46). In HypB, K153, is contributed to the active site from the adjacent monomer upon GTP-
dependent dimerization and might be crucial for stabilizing the active site (24). While an 
equivalent residue does not exist in MeaB, either K106 or R108 might play such a role. 
Alternatively, R108 might be important for GTP binding based on the crystal structure of 
MeaBGMPPNP (46). 
In the Ras GTPases, nucleotide hydrolysis elicits conformational rearrangements in switch I 
(also known as the effector recognition motif) that are recognized by downstream target proteins 
(45,47). Recent evidence suggests that, besides switch II, MeaB uses a rare motif, switch III, for 
transmission of the chaperone function of MeaB and the GAP function of MCM (46,48). Thus, 
the role of switch I in transmitting the chaperone functions of MeaB is unknown. 
In this study, we examined the role of switch I in supporting MeaB functions. We introduced 
conservative or alanine substitution mutations at strongly conserved positions in the switch I 
sequence. We provide evidence that switch I plays a critical role in the GTPase-gated transfer of 
AdoCbl from ATR to MCM and the displacement of the inactive cob(II) alamin cofactor from 
MCM. Our study suggests that isolated MeaB might catalyze GTP hydrolysis by a different 
mechanism than when it is in complex with MCM. 
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5.3 Experimental Procedures 
 5.3.1 Materials-AdoCbl, GMPPNP, ATP, GTP, methylmalonic acid, coenzyme-A, and other 
reagent grade chemicals were purchased from Sigma. Trifluoroacetic acid was purchased from 
Aldrich. Methylmalonyl-CoA was synthesized using malonyl-CoA synthetase, purified as 
described previously (49). A µBondapakTM NH2 10 µm, 125 Å 3.9 x 300 mm column was used 
for the HPLC separation and determination of guanosine nucleotides purchased from Waters. 
5.3.2 Construction of site-specific mutants–Plasmids encoding the M. extorquens ATR and 
MCM were generous gifts from Mary E. Lidstrom (University of Washington, Seattle). A 
synthetic gene encoding M. extorquens AM1 MeaB was used for the generation of site-specific 
mutants of MeaB using a Quickchange kit (Agilent, Santa Clara, CA) according to the 
manufacturer’s protocol. The following forward primers were used to generate the mutations. 






 5.3.3 Enzyme Purification–Recombinant M. extorquens MeaB, MCM, and ATR were 
expressed and purified from E. coli BL-21 (DE3) as described previously (15,50). The purified 
enzymes were flash frozen in liquid nitrogen and stored at -80 °C in 50 mM HEPES buffer, pH 
8.0, containing 0.3 M KCl, 10 mM MgCl2, 10% glycerol (Buffer A). 
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5.3.4 Thermodynamics of GMPPNP-binding–Isothermal titration calorimetry (ITC) 
experiments were performed at 10 °C in Buffer A using a 300 µl injection syringe and a 1.43 ml 
injection cell. Samples were prepared by filtration through a 0.2 µm filter and then degassed 
under vacuum at 4 °C using a ThermoVac sample degasser. Each titration was performed at least 
in duplicate. GMPPNP (10 µl injections of 150-400 µM) was added to 10-25 µM MeaB. The 
data were analyzed using a two-site binding model using the MicroCal ORIGIN program. Values 
for the dissociation constant at sites 1 and 2 were then compared to the values obtained from the 
solution of the Gibbs free energy equation: ΔGo = -RTln(KA). 
5.3.5 Enzyme Inactivation Assays with Switch I Mutants–Inactivation of MCM under 
steady-state turnover conditions was examined by UV/visible spectroscopy by enzyme-
monitored conversion of cob(II)alamin to aquocob(III)alamin (OH2Cbl) at 20 °C in 0.1 M 
potassium phosphate at pH 7.5 containing 10 mM MgCl2. The reactions and sample preparations 
were performed in the dark to avert spurious formation of OH2Cbl by photolysis of AdoCbl. 
Samples were prepared by the addition of reactions components in the order described below. 
MCM (25-30 µM) was reconstituted using an equimolar concentration of AdoCbl. A molar 
excess (35-40 µM) of MeaB was added to the MCM holoenzyme to obtain the MCM:MeaB 
complex. GMPPNP was then added to the reaction mixture to a final concentration of 1-2 mM 
and the reaction was initiated by the addition of methylmalonly-CoA to a final concentration of 
4.5-5 mM. The rates of inactivation were determined by plotting the change in absorbance at 351 
nm, corresponding to OH2Cbl formation, as a function of time. The kinetic traces were best fit by 
a single exponential equation: ΔAt = Ao – ΔApe(-kt), where ΔAt is the absorbance at 351 nm as a 
function of time, Ao is the initial absorbance of cob(II)alamin, ΔAp is the reaction phase 
amplitude for OH2Cbl formation, and k is the observed rate constant for MCM inactivation. 
 117 
5.3.6 Assay for transfer of AdoCbl from ATR to MCM with Switch I Mutants –The 
ATP-dependent transfer of AdoCbl from ATR to the MCM:MeaBGMPPNP complex was 
performed in the dark at 20 °C and monitored by UV/visible spectroscopy. Two equivalents of 
AdoCbl were added to one equivalent of ATR to generate holo-ATR in Buffer A. The apo-
MCM:MeaBGMPPNP complex was reconstituted in Buffer A by mixing 40-50 µM MCM with 
an equimolar concentration of AdoCbl and 50-60 µM MeaB. GMPPNP was added to a final 
concentration of 1 mM. Holo-ATR (2:1 AdoCbl:ATR) and the MCM:MeaBGMPPNP complex 
(40-50 µM) were mixed and incubated for 10 min at 20 °C before addition of ATP to a final 
concentration of 5 mM. Release/transfer of AdoCbl from ATR was calculated using a Δε525 = 
6.69 mM-1 cm-1. Bound versus free cofactor was separated using an Amicon centrifuge filter (10 
kDa cutoff, 20 min, 4 °C, 16,000 x g). The concentration of free AdoCbl in the filtrate was 
calculated using ε525 = 8.0 mM-1cm-1. 
5.3.7 Ejection of Cob(II)alamin by Switch I Mutants–MCM (30-40 µM) was mixed with 
45-60 µM MeaB (wild-type, D92A, D92N, D105A, or K106A) in Buffer A at 20 °C under 
strictly anaerobic conditions such that the [MCM]:[MeaB] ratio is 1:1.5. Cob(II)alamin was 
generated by reduction of OH2Cbl with tris (2-carboxyethyl) phosphine hydrochloride (TCEP) 
and  was added to a final concentration equal to that of the MCM:MeaB wild-type or mutant 
complex. The reaction mixture was incubated for 10 min at 20 °C. GMPPNP in anaerobic Buffer 
A was added to a final concentration of 2 mM. The mixture was then incubated for 20 min at 20 
°C. Subsequently, the sample was made aerobic by air oxidation for 2 h and then applied to a 
Centricon YM10 filter (10 kDa cutoff) to separate free from bound OH2Cbl., Cob(II)alamin (but 
not OH2Cbl) can be released from MCM and is subsequently oxidized to OHCbl, which was 
quantified using ε535 = 9.3 mM-1cm-1. 
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5.3.8 GTPase activity of MeaB–The GTPase activity of MeaB was determined using an 
HPLC assay as described previously (4). 
5.3.9 Size-Exclusion Chromatography–Samples were prepared in the dark in Buffer A 
containing 0.5 mM GDP and 80-90 µM of wild-type or mutant MeaB ± equimolar MCM and 0.5 
mM AdoCbl in a total volume of 150 µL and loaded onto a Superdex-200 HR 10/30 column 
equilibrated with Buffer A. The protein complexes were eluted in the dark to minimize 
photolysis of AdoCbl.  
 
5.4 Results 
5.4.1 Impact of switch I mutations on formation of the MCM:MeaB Complex 
The effect of switch 1 mutations on formation of the MCM:MeaB complex was probed by 
size-exclusion chromatography (Fig. 5.3). We have previously shown that wild-type MCM (142 
kDa, peak a) and MeaB (68 kDa, peak b) elute at a volume consistent with their predicted 
molecular masses (Fig. 5.3) (48). Reconstitution of the wild-type and mutant MCM:MeaB 
complexes (65-70 µM) was performed by combining the component proteins in a 1:1 molar ratio 
in buffer containing a molar excess of GDP and AdoCbl. The wild-type MCM:MeaB complex 
migrated with a molecular mass of 243 kDa, which is consistent with a complex having 1:1 
stoichiometry (Fig. 5.3, peak c). A higher order aggregate of the MCM:MeaB complex migrates 
with an apparent molecular mass of ~600 kDa (peak d). The individual switch I mutants of 
MeaB exhibit molecular masses that are comparable to that of the wild-type MeaB homodimer 
(63-71 kDa) (Fig. 5.3). The R108M and D92A switch I mutations shift the equilibrium away 
from the 1:1 MCM:MeaB complex and toward the higher order oligomer (peak d). The D92N, 
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D105A, and K106A have the opposite effect, shifting the equilibrium toward the stoichiometric 
complex (peak c). The peak eluting at ~24 ml corresponds the free ligands. 
 
5.4.2 Effect of switch I mutations on GMPPNP binding  
The active sites of the isolated MeaB homodimer exhibit negative cooperativity for 
GMPPNP (3,28). The KD values for GMPPNP binding to sites 1 and 2 in wild-type MeaB are: 
 
Figure 5.3. Impact of switch I mutations on formation of the MCM:MeaB complex. Size-
exclusion chromatographic determination of the molecular masses of isolated wild-type and 
switch I mutants of MeaB (blue line) with added GDP and of the complexes formed with MCM 
(black line) in the presence of GDP and AdoCbl. The elution of MCM alone (red line) with 
added AdoCbl and GDP is shown in the bottom trace. The peak eluting at ~24 ml corresponds to 
free GDP and AdoCbl. The peaks labeled a-d correspond to molecular masses of 68 kDa (MeaB 
homodimer), 144 kDa (MCM heterodimer), 243 kDa (a 1:1 MCM:MeaB complex), and 600 kDa 
(a high order oligomer of MCM:MeaB), respectively. 
 
0.8 ± 0.4 µM and 9.5 ± 1.9 µM, respectively (Table 5.1). In contrast, GMPPNP binding to 
R108M was not detected. Efforts to examine nucleotide binding to R108A were unsuccessful 









switch I mutations on the KD for GMPPNP binding at site 1 ranges from 0.05 ± 0.01 µM 
(D105A) to 1.8 ± 0.2 µM (D92A). The KD for GMPPNP binding at site 2 of switch I mutants 
ranges from 1.6 ± 0.2 µM (D105A) to 14.5 ± 4.1 µM (K106A).  
 
5.4.3 GTPase activity of switch I mutants 
 The D92A, D92N, D105A and K106A mutations, have virtually no impact on the intrinsic 
GTPase activity compared to wild-type MeaB and exhibit kcat values ranging from 0.031 ± 0.003 
min-1 to 0.05 ± 0.01 min-1 (Table 5.2).  
Enzyme KD (µM) 
 Site 1  Site 2 
Wild-typea 0.81 ± 0.50  9.5 ± 1.9 
D92A 1.77 ± 0.22  14.3 ± 1.0 
D92N 1.06 ± 0.30  12.0 ± 2.1 
D105A 0.05 ± 0.01  1.6 ± 0.2 
K106A 0.34 ± 0.09  14.5 ± 4.1 
R108M NDb  NDb 
                                     
Table 5.1. Dissociation constants for GMPPNP binding to switch I mutants of MeaB. 
aDetermined previously (2). bNot detectable under assay conditions.  
 
 
Consistent with its inability to bind GMPPNP, R108M MeaB shows no GTPase activity. Wild-
type MeaB exhibits an ~100-fold increase in the kcat for GTP hydrolysis in the MCM:MeaB 
complex. By comparison, the active switch I mutants are significantly desensitized to the GAP 
function of MCM. In the presence of a 1.5 molar excess of MCM, the value of kcat is increased 
by 5- to 7-fold in D92A and D92N MeaB, respectively. The D105A and K106A mutations lead 





Enzyme kcat (min-1)   
 - MCM  + MCM  Fold GAP-Activation 
Wild-typea 0.039 ± 0.003  4.08 ± 0.20  102 
D92A 0.039 ± 0.006  0.19 ± 0.04  4.9 
D92N 0.036 ± 0.005  0.25 ± 0.04  6.9 
D105A 0.031 ± 0.003  0.36 ± 0.03  11.6 
K106A 0.051 ± 0.011  1.21 ± 0.20  23.7 
R108M NDb  NDb  - 
 
Table 5.2. Kinetic parameters for GTP hydrolysis by MeaB mutants. aAs determined 
previously (4). bNot detected under assay conditions. 
 
5.4.4 Switch I mutations do not impact rate of MCM inactivation 
Loss of the 5´-deoxyadenosine group from the active site during steady-state turnover results 
in gradual inactivation of MCM (3). Addition of MeaB increases the rate of MCM inactivation 
by ~1.3-fold (Fig. 5.4a). However, inclusion of GDP, GTP, or GMPPNP leads to a 30-fold (3.0 x 
10-4 min-1) decrease in the rate of MCM inactivation (Fig. 5.4a). In the presence of GMPPNP, the 
switch I mutants D92A, D92N, D105A, and K106A, do not appreciably impact the rate of MCM 
inactivation compared to wild-type MeaB. The rate of MCM inactivation in the complexes 
formed between MCM and switch I mutants of MeaB ranged from 2.6 x 10-4 (K106A) to 3.4 x 
10-4 min-1 (D92A). 
 
5.4.5 Effect of switch I mutations on GTPase-gated AdoCbl transfer from ATR to MCM 
Binding of ATP to ATR and hydrolysis of GTP in the MCM:MeaB complex result in the 
transfer of 1 equivalent of AdoCbl from ATR to MCM (50,51). Substitution of GTP with 
GMPPNP blocks AdoCbl transfer to the MCM:MeaB complex and instead, 0.06 equivalents of 
AdoCbl are released into solution (Fig. 5.4b). Thus, wild-type MeaB couples GTP hydrolysis to 
AdoCbl transfer from ATR to MCM. However, mutations at D92, D105 and K106 in MeaB lead 
to uncoupling of the GTPase activity from AdoCbl transfer. When GMPPNP is bound to the 
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MCM:MeaB (D92N or K106A) complexes, ~0.42 equivalents of AdoCbl are transferred to 
MCM while ~0.78 equivalents of AdoCbl are transferred to MCM in the presence of D92A or 
D105A MeaB.  
 
5.4.6 Reactivation of MCM by switch I mutants 
The dissociation of 5´-deoxyadenosine during steady-state turnover leads to the other part of 
the cofactor, cob(II)alamin, stranded in the MCM active site and consequent accumulation of 
inactive MCM (4). It has been previously demonstrated that MeaB triggers the GTP-dependent 
expulsion of inactive cob(II)alamin from MCM during turnover (3). This rescue function of 
MeaB is specific for expulsion of cob(II)alamin, but not the oxidized product, OH2Cbl. Addition 
of GMPPNP to the wild-type MeaB:MCMcob(II)alamin complex triggers ejection of ~97% 
cob(II)alamin from MCM under anaerobic conditions (Fig. 5.4c). This displaced cofactor can be 
separated under aerobic conditions from enzyme-bound cob(II)alamin using a Centricon filter, 
and the concentration of free OH2Cbl can be determined from the absorbance at 351 nm. 
Addition of GMPPNP to the MCM:MeaB complex loaded with cob(II)alamin and MeaB 
harboring D92A, D92N, D105A, or K106A mutations leads to ejection of only 51-66 % of 
cob(II)alamin (Fig. 5.4c). 
 
5.5 Discussion 
 Nearly 40 pathogenic mutations have been described in CblA that are associated with 
methylmalonic aciduria (12,52-55). MeaB, the closely related bacterial ortholog of CblA, 
represents the best-studied chaperone of a B12-dependent isomerase and is among the most 
thoroughly studied NTPase metallochaperone proteins (2-4,15,28). MeaB appears to be novel 
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among other NTPase metallochaperones by virtue of its deployment of a third switch motif, 
switch III, for effecting its chaperone functions (46). Recent evidence indicates that 
conformational changes in switch III are coupled to canonical nucleotide-dependent 
conformational changes in switch II (46,48). In contrast, the role of switch I in bidirectional 
signaling had not been assessed prior to this study. 
 The inability to capture the crystal structures of a switch I motif in a catalytically active 
conformation containing Mg2+ ion has limited our insights into the functional role of switch I in 
MeaB catalysis (28,46,48). The NTPase activity is highly sensitive to amino acid substitutions at 
conserved positions in switch I and II in P-loop NTPases (34,40,56). Mutation of the catalytic 
glutamine in the ExxGQ switch II motif of Ras-related proteins abolishes GTPase activity, 
activating Ras-proteins toward malignant transformation (32). Similarly, substitution of the 
putative Aspcat residue in the switch I region of SIMIBI NTPases leads to a substantial decrease 
in the rate of nucleotide hydrolysis (31). Surprisingly, substitution of the predicted Aspcat in 
MeaB, D92, and other conserved switch I residues in MeaB has virtually no impact on its 
intrinsic GTPase activity (Table 2). In contrast, enhancement of GTP hydrolysis in the 
MCM:MeaB complex is suppressed by mutations in switch I. Based on sequence relationship to 
HypB and other G3E proteins, the switch I motif of MeaB is predicted to supply the active site 
with catalytic residues for polarizing a water molecule (D92), ligating Mg2+ (D105), and binding 
the β- and γ-phosphate oxygens of GDP/GTP (R108) (Fig. 5.2) (24,28). The results presented 
here suggest that at least part of the GAP function of MCM is derived by stabilization of a 
catalytically active conformation of switch I loop of MeaB, which is predicted to resemble the 





Figure 5.4. The impact of switch I MeaB mutations on the Chaperone Functions of MeaB. 
a) Time-dependent inactivation of MCM in complex with wild-type or switch I mutants of MeaB 
and in the presence of 5 mM methylmalonyl-CoA at pH 7.5, 20 °C. The plot shows the time-
dependent formation of H2OCbl detected at 351 nm and is representative of at least two 
experiments. The data points were fitted using a single exponential equation described under 
Experimental Procedures. b) ATP-dependent release or transfer of AdoCbl from ATR to the 
MCM:MeaB complex (containing wild-type or switch I mutant MeaBs) in the presence of 
GMPPNP. The data represent the average of at least 2 independent experiments. c) Displacement 































































addition of GMPPNP under anaerobic conditions. The data are the average of at least 2 
independent experiments. 
 
 Mutations at conserved positions in the switch I motif of MeaB also impair its ability to 
regulate cobalamin binding to and displacement from MCM. In Gα proteins, GTP hydrolysis 
triggers a conformational rearrangement in switch I for signaling to downstream effector proteins 
(18,57). NifH is a SIMIBI class ATPase that, along with the MoFe protein comprises a two-
component complex involved in nitrogenase maturation (1). Mutation of the residue in NifH that 
corresponds to D92 in MeaB severely impairs the ability of NifH to catalyze GTP hydrolysis and 
to effect the maturation of the MoFe cofactor in nitrogenase (31). Thus, the disruption of GTPase 
activity among G3E G-proteins disrupts their chaperone function, supporting a role for D92 in 
catalysis in the MCM:MeaB complex. 
 The GAP function of MCM might also be conveyed in trans via residues from MCM, e.g. by 
contribution of an arginine “finger” to the MeaB/CblA active site. A pathogenic mutation in 
human MCM, R616C maps to the surface of MCM from Propionibacterium shermanii (58,59). 
Mimicking the R616C mutation in the M. extorquens MCM (R585C) resulted in significantly 
reduced GAP function by MCM (3). However, in the absence of a crystal structure of the 
MCM:MeaB complex, the role of the R585 residue in the M. extorquens MCM is uncertain. The 
strong conservation of R108 in MeaB and its orthologs, and the inability of the R108M mutant to 
bind GMPPNP and hydrolyze GTP identify R108 as a potential arginine “finger” provided in cis 
by MeaB. 
 The K106 residue is conserved in the switch 1 motif of MeaB and its orthologs, but not 
among other G-protein metallochaperones (12,16,28). In the various structures of MeaB, K106 is 
either positioned on a disordered loop, is solvent exposed, or hydrogen bonded to the carbonyl 
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groups of L103 in switch I or I120 on the β3 sheet (28,46,48). Thus, the basis for disruption of 
the GTPase activity in the MCM:MeaB complex of the K106A mutant is not apparent. In the 
structure of HypBGTPγS, K153 is supplied to the active site from the surface of the adjacent 
subunit and is involved in binding the terminal phosphate of GTPγS and the active site Mg2+ ion 
(24). Wittinghofer and colleagues proposed that K153 is a critical factor stabilization of the 
HypB active site (24). The switch I region of MeaB would have to undergo a significant 
conformational change in the MCM:MeaB complex for K106 to serve a role equivalent to K153 
in HypB. 
 In this study, we demonstrate that mutations to switch I of MeaB significantly reduce both its 
gating function for regulating AdoCbl transfer from ATR to MCM and its rescuing function for 
ejecting inactive cobalamin from MCM (Fig 5.4b and 5.4c). The disruption of these functions 
suggests that switch I is critical for signaling the GTP-bound conformation of MeaB to MCM. 
This model is also consistent with the predicted involvement of D105 and D92 in stabilizing the 
GTP-bound state of the MeaB by ligating Mg2+ via D105 and the active site water molecules by 
D92 (Fig. 5.2b and 5.2c).  
 The involvement of K106 in signaling the chaperone functions of MeaB to MCM is not 
apparent from the various crystal structures of MeaB. The surface exposure of K106 and the 
adverse impact of the K106A mutation on gating AdoCbl binding and stimulating ejection of 
cob(II)alamin, suggest that  this residue might be important for communicating directly with the 
B12-binding domains of MCM. 
 G-proteins and ATPases couple the free energy of nucleotide binding, exchange, and 
phosphodiester hydrolysis to conformational changes in flexible switch regions to effect 
regulation of diverse functions ranging from DNA replication, protein synthesis and localization, 
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to cytoskeletal dynamics, and coenzyme trafficking and assimilation (1,18,34,44,47). Recent 
studies of the vast pool of evolutionarily diverse G-proteins and ATPases have begun to uncover 
multiple strategies by which these proteins transduce signals. The G3E metallochaperone MeaB, 
with its atypical active site and an additional switch motif illustrates the diversity of catalytic and 
signaling strategies within a single G-protein. The results presented in this study demonstrate that 
MeaB also relies on canonical signaling and catalytic strategies for its chaperone and enzymatic 
functions. 
 
5.6 Ongoing Research and Future Directions 
5.6.1 Background 
 Isobutyryl-CoA mutase (ICM) is an AdoCbl-dependent isomerase that catalyze the 
interconversion of isobutyryl-CoA to n-butyryl-CoA, a substrate for bacterial polyketide 
biosynthesis (60). ICM proteins are closely related to methylmalonyl-CoA mutase (MCM) 
proteins. In mammals, MCM relies upon a cobalamin assimilation and trafficking pathway for 
the synthesis and delivery of its cofactor, AdoCbl. The fidelity of AdoCbl docking in MCM, as 
well the propensity of the cofactor to escape from the catalytic cycle, is regulated by an auxiliary 
pathway G-protein that is CblA in humans and MeaB in Methylbacterium extorquens (2-
4,7,8,15-17,28). Catalytic turnover in MCM and ICM proteins involves homolysis of the cobalt-
carbon bond of AdoCbl. The dissociation of 5’-deoxyadenosine from the active site during 
catalytic turnover results in inactivation of MCM and ICM. Genetic disruptions to the genes 
encoding CblA or MeaB result is dyfunctions in MCM activity, reduced AdoCbl, and revealed a 
role for these auxiliary G-proteins in chaperoning the activity and assembly of MCM proteins 
(12,52,54,55).  
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 Until recently, it was unclear how ICM averts inactivation of its cofactor during catalysis, 
whether ICM proteins, like MCM, were protected by dedicated chaperones, and how the fidelity 
of AdoCbl docking into the ICM active site is achieved. A detailed bioinformatic screen revealed 
that genes encoding ICM proteins in >70 prokaryotes were incorrectly annotated as MCM (61). 
It was shown that these genes encoded a fusion between ICM and its G-protein chaperone 
inserted between the B12- and substrate-binding domains. The “G-domain” has been 
subsequently designated as MeaI and is a paralog of MeaB, and the fusion protein has been 
designated as IcmF (ICM-fused) to distinguish it from the stand-alone ICMs.  
 The MeaI domain of IcmF from Geobacillus kaustophilus (Gk) mediates the transfer of 
AdoCbl from Gk ATR to Gk IcmF (62). As with MeaB, the non-hydrolyzable analog of GTP, 
GMPPNP, blocks transfer of AdoCbl from ATR to Gk IcmF, indicating that cofactor transfer 
requires GTP hydrolysis. Despite the ability of Gk IcmF to bind and hydrolyze ATP, the transfer 
of AdoCbl from ATR to IcmF is unaffected by AMPPNP, the non-hydrolyzable analog of ATP. 
Unlike MeaB, the MeaI domain of IcmF does not slow the rate of ICM inactivation and does not 
stimulate ejection of cob(II)alamin from IcmF that has become uncoupled from 5’-
deoxyadenosine. The basis for these differences as still unclear.  
 The structure of IcmF in complex with AdoCbl and GDP was recently solved in 
collaboration between our group (Dr. Valentin Cracan and Dr. Ruma Banerjee) and Dr. 
Catherine Drennan’s group (Marco Jost) at MIT. While the full crystal structure remains to be 
published, preliminary analysis of the structure suggests one mechanism for allosteric 
communication in which a switch I arginine residue contacts two residues in the adjacent B12-
binding domain. The corresponding residues in the M. extorquens proteins are D624 and E625 in 
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Figure 5.6. Sequence alignment of conserved regions of the B12-binding domains of M. 
extrorquens MCM and Geobacillus kaustophilus IcmF. Identical matches between the aligned 
sequences are boxed in dark grey and conservative changes are shaded in light grey and marked 
with a colon.  
 
5.6.2 Current and Future Research 
 To assess the importance of the D624 and E625 residues in the B12-binding domain of the M. 
extorquens MCM, we have introduced the D624A, E625A, and the double D624A/E625A 
mutations and expressed and purified the single mutants. Expression studies of the 
D624A/E625A double mutant are underway, and we are optimistic that it too will be expressed 
in a soluble form. 
 Following purification of each mutant, we will verify its activity in the MCM assay via 
enzyme-monitored inactivation by tracking formation of cob(II)alamin. If formation of the 
cob(II)alamin intermediate or the oxidatively inactivated H2OCbl is not observed, we will 
analyze the reaction mixtures for product formation using gas chromatography. The 
thermodynamics of binding MeaB ± nucleotides to the mutant proteins will be quantitatively 
evaluated by ITC. If formation of the MeaB:MCM mutant complexes is not apparent from ITC 
(e.g., if the heat release is low), analytical size-exclusion chromatography will be used to 
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Binding of AdoCbl to MCM and to the MCM:MeaB complex, and the influence of GDP and 
GMPPNP will also be determined by ITC. The thermodynamics of binding of nucleotides to 
MeaB in the complex formed between MeaB and MCM mutants will also be investigated by 
ITC. If formation of the MCM:MeaB complex, the affinity of MCM for AdoCbl in the 
MCM:MeaB complex, and the affinity of MeaB for nucleotides in the MCM:MeaB complex are 
not affected by the D624A, E625A and D624A/E625A mutations, the chaperone and GAP 
function of MeaB and MCM, respectively, will be assessed as described under Materials and 
Methods. If any of the alanine-substituted MCM variants exhibit disrupted cofactor or nucleotide 
binding, enzyme activity, or the formation of the MCM:MeaB complexes, conservative 
mutations (D625N and E625Q) will be introduced and examined as described above. 
 
5.7 Final Remarks 
 The body of work presented in this doctoral dissertation has significantly increased our 
understanding of the mechanism of allosteric communication that guides AdoCbl docking to, 
protection in, and release from MCM (7,50). Our studies have helped elucidate the complicated 
mechanism by which MeaB and, most likely, its orthologs, signal nucleotide binding and 
hydrolysis to orchestrate its chaperone functions. However, an important gap that remains is 
structural insight into the active site rearrangement of MeaB that is predicted to occur in the 
MCM:MeaB complex. To that end, we are using both crystallographic and small-angle X-ray 
scattering approaches to obtain insights into the structure of the MCM:MeaB complex. However, 
to date, these efforts have not been successful due to the very high solubility and heterogeneity 
of the MCM: MEaB complex. Analytical gel filtration analysis reveals that the stoichiometry of 
the MCM:MeaB complex is sensitive to point mutations with the equilibrium shifting in some 
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instances almost completely to the 1:1 complex. This incrased homogeneity might bode well for 
future structural studies of the complex. The primary technique that we have chosen to study the 
mechanism of allostery in the chaperone and GAP functions of MeaB and MCM, respectively, 
has been site-directed mutagenesis followed by the biochemical characterization of these 
mutants. To this end, I have created twenty-six unique mutant MeaB constructs and six mutant 
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